{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b5de39ad",
   "metadata": {},
   "source": [
    "## Importing libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "cd1b6e7f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re\n",
    "import tensorflow as tf\n",
    "import matplotlib.pyplot as plt\n",
    "from tensorflow.keras import layers\n",
    "from tensorflow import keras\n",
    "from sklearn.preprocessing import MultiLabelBinarizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "from ast import literal_eval\n",
    "\n",
    "import nltk\n",
    "#nltk.download('stopwords')\n",
    "#nltk.download('wordnet')\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.tokenize import sent_tokenize\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "\n",
    "lemmatizer = WordNetLemmatizer()\n",
    "stopword = set(stopwords.words('english'))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0fb91246",
   "metadata": {},
   "source": [
    "## Opening csv file and removing redundant ID column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "17d1ebef",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('Covid_Papers.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "5c61409c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.drop(\"Unnamed: 0\", axis =1, inplace = True)\n",
    "df['abstract'] = df['title'] + ' ' + df['abstract']\n",
    "df.drop(\"title\", axis =1, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "a6791fa8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>abstract</th>\n",
       "      <th>tags</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Real-World Experience with COVID-19  Including...</td>\n",
       "      <td>['Aged', 'Aged, 80 and over', 'Antibodies, Mon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Successful outcome of pre-engraftment COVID-19...</td>\n",
       "      <td>['COVID-19*', 'Hematopoietic Stem Cell Transpl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>The impact of COVID-19 on oncology professiona...</td>\n",
       "      <td>['Burnout, Professional* / epidemiology', 'COV...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ICU admission and mortality classifiers for CO...</td>\n",
       "      <td>['Bayes Theorem', 'COVID-19*', 'Hospitalizatio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Clinical evaluation of nasopharyngeal  midturb...</td>\n",
       "      <td>['COVID-19 Testing', 'COVID-19* / diagnosis', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5468</th>\n",
       "      <td>Hypersensitivity Reactions to Vaccines  Curren...</td>\n",
       "      <td>['Anaphylaxis* / chemically induced', 'COVID-1...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5469</th>\n",
       "      <td>Rooming-in  Breastfeeding and Neonatal Follow-...</td>\n",
       "      <td>['Breast Feeding*', 'COVID-19*', 'Female', 'Fo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5470</th>\n",
       "      <td>Acute Abducens Nerve Palsy Following the Secon...</td>\n",
       "      <td>['Abducens Nerve Diseases* / chemically induce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5471</th>\n",
       "      <td>Planning and Implementing the Protocol for Psy...</td>\n",
       "      <td>['COVID-19*', 'Delivery of Health Care', 'Huma...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5472</th>\n",
       "      <td>Prolonged corrected QT interval in hospitalize...</td>\n",
       "      <td>['COVID-19*', 'Electrocardiography', 'Humans',...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5473 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               abstract  \\\n",
       "0     Real-World Experience with COVID-19  Including...   \n",
       "1     Successful outcome of pre-engraftment COVID-19...   \n",
       "2     The impact of COVID-19 on oncology professiona...   \n",
       "3     ICU admission and mortality classifiers for CO...   \n",
       "4     Clinical evaluation of nasopharyngeal  midturb...   \n",
       "...                                                 ...   \n",
       "5468  Hypersensitivity Reactions to Vaccines  Curren...   \n",
       "5469  Rooming-in  Breastfeeding and Neonatal Follow-...   \n",
       "5470  Acute Abducens Nerve Palsy Following the Secon...   \n",
       "5471  Planning and Implementing the Protocol for Psy...   \n",
       "5472  Prolonged corrected QT interval in hospitalize...   \n",
       "\n",
       "                                                   tags  \n",
       "0     ['Aged', 'Aged, 80 and over', 'Antibodies, Mon...  \n",
       "1     ['COVID-19*', 'Hematopoietic Stem Cell Transpl...  \n",
       "2     ['Burnout, Professional* / epidemiology', 'COV...  \n",
       "3     ['Bayes Theorem', 'COVID-19*', 'Hospitalizatio...  \n",
       "4     ['COVID-19 Testing', 'COVID-19* / diagnosis', ...  \n",
       "...                                                 ...  \n",
       "5468  ['Anaphylaxis* / chemically induced', 'COVID-1...  \n",
       "5469  ['Breast Feeding*', 'COVID-19*', 'Female', 'Fo...  \n",
       "5470  ['Abducens Nerve Diseases* / chemically induce...  \n",
       "5471  ['COVID-19*', 'Delivery of Health Care', 'Huma...  \n",
       "5472  ['COVID-19*', 'Electrocardiography', 'Humans',...  \n",
       "\n",
       "[5473 rows x 2 columns]"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "64f5a588",
   "metadata": {},
   "source": [
    "## Creating helper functions to clean text for later"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "25f6b2ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "def remove_punctuation(text):\n",
    "    \n",
    "    # punctuations except -  \n",
    "    punc ='''?!.,:;_—[](){}'\"`~|\\/@#$%^&+=*'''\n",
    "    for i in text:\n",
    "        if i in punc:\n",
    "            text = text.replace(i, ' ')            \n",
    "    return text.strip()\n",
    "\n",
    "def preprocess(text):\n",
    "    \n",
    "    # lower casing\n",
    "    text=text.lower()\n",
    "    \n",
    "    # stopword removal\n",
    "    text = [word for word in text.split(' ') if word not in stopword]\n",
    "    text=\" \".join(text)\n",
    "    \n",
    "    # lemmatization\n",
    "    text = [lemmatizer.lemmatize(word) for word in text.split(' ')]\n",
    "    text = \" \".join(text)\n",
    "    \n",
    "    # removing words containing only numbers\n",
    "    text = re.sub(r'\\s[0-9]+\\s', '', text)\n",
    "    \n",
    "    # remove extra spaces\n",
    "    text = re.sub(\"\\s\\s+\", \" \", text)   \n",
    "    return text.strip()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "1f8c2df0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>abstract</th>\n",
       "      <th>tags</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Real-World Experience with COVID-19  Including...</td>\n",
       "      <td>['Aged', 'Aged, 80 and over', 'Antibodies, Mon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Successful outcome of pre-engraftment COVID-19...</td>\n",
       "      <td>['COVID-19*', 'Hematopoietic Stem Cell Transpl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>The impact of COVID-19 on oncology professiona...</td>\n",
       "      <td>['Burnout, Professional* / epidemiology', 'COV...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ICU admission and mortality classifiers for CO...</td>\n",
       "      <td>['Bayes Theorem', 'COVID-19*', 'Hospitalizatio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Clinical evaluation of nasopharyngeal  midturb...</td>\n",
       "      <td>['COVID-19 Testing', 'COVID-19* / diagnosis', ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            abstract  \\\n",
       "0  Real-World Experience with COVID-19  Including...   \n",
       "1  Successful outcome of pre-engraftment COVID-19...   \n",
       "2  The impact of COVID-19 on oncology professiona...   \n",
       "3  ICU admission and mortality classifiers for CO...   \n",
       "4  Clinical evaluation of nasopharyngeal  midturb...   \n",
       "\n",
       "                                                tags  \n",
       "0  ['Aged', 'Aged, 80 and over', 'Antibodies, Mon...  \n",
       "1  ['COVID-19*', 'Hematopoietic Stem Cell Transpl...  \n",
       "2  ['Burnout, Professional* / epidemiology', 'COV...  \n",
       "3  ['Bayes Theorem', 'COVID-19*', 'Hospitalizatio...  \n",
       "4  ['COVID-19 Testing', 'COVID-19* / diagnosis', ...  "
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "e86f7b7a",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['abstract']=df['abstract'].apply(remove_punctuation)\n",
    "df['abstract']=df['abstract'].apply(preprocess)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "75c93b26",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"['COVID-19*', 'Hematopoietic Stem Cell Transplantation*', 'Humans', 'Immunity, Cellular', 'Pandemics', 'SARS-CoV-2']\""
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.loc[1][1]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9dde4504",
   "metadata": {},
   "source": [
    "## Making column into string literals for easier computation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "3ec182ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([list(['Aged', 'Aged, 80 and over', 'Antibodies, Monoclonal, Humanized / therapeutic use*', 'Antibodies, Neutralizing / therapeutic use', 'Antigens, Viral / analysis', 'COVID-19 Testing', 'COVID-19* / diagnosis', 'COVID-19* / therapy', 'Hospitals', 'Humans', 'Middle Aged', 'Retrospective Studies', 'South Dakota']),\n",
       "       list(['COVID-19*', 'Hematopoietic Stem Cell Transplantation*', 'Humans', 'Immunity, Cellular', 'Pandemics', 'SARS-CoV-2']),\n",
       "       list(['Burnout, Professional* / epidemiology', 'COVID-19* / epidemiology', 'COVID-19* / psychology', 'Europe / epidemiology', 'Female', 'Health Personnel* / psychology', 'Humans', 'Medical Oncology*', 'Pandemics', 'Societies, Medical']),\n",
       "       list(['Bayes Theorem', 'COVID-19*', 'Hospitalization', 'Humans', 'Intensive Care Units', 'Retrospective Studies', 'SARS-CoV-2']),\n",
       "       list(['COVID-19 Testing', 'COVID-19* / diagnosis', 'Humans', 'Nasopharynx', 'SARS-CoV-2*', 'Saliva', 'Specimen Handling'])],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"tags\"] = df[\"tags\"].apply(\n",
    "    lambda x: literal_eval(x)\n",
    ")\n",
    "df[\"tags\"].values[:5]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e61d64c",
   "metadata": {},
   "source": [
    "## Splitting data into train, val and test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "9107b452",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "D:\\Programming\\Anaconda\\lib\\site-packages\\pandas\\core\\frame.py:4906: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  return super().drop(\n"
     ]
    }
   ],
   "source": [
    "test_split = 0.1\n",
    "\n",
    "# Initial train and test split.\n",
    "train_df, test_df = train_test_split(df, test_size=test_split)\n",
    "\n",
    "# Splitting the test set further into validation\n",
    "# and new test sets.\n",
    "val_df = test_df.sample(frac=0.5)\n",
    "test_df.drop(val_df.index, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "6100585e",
   "metadata": {},
   "outputs": [],
   "source": [
    "tags = tf.ragged.constant(train_df[\"tags\"].values)\n",
    "lookup = tf.keras.layers.StringLookup(output_mode=\"multi_hot\")\n",
    "lookup.adapt(tags)\n",
    "vocab = lookup.get_vocabulary()\n",
    "\n",
    "\n",
    "def invert_multi_hot(encoded_labels):\n",
    "    hot_indices = np.argwhere(encoded_labels == 1.0)[..., 0]\n",
    "    return np.take(vocab, hot_indices)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "26b9ae39",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['[UNK]',\n",
       " 'Humans',\n",
       " 'SARS-CoV-2',\n",
       " 'COVID-19*',\n",
       " 'Pandemics',\n",
       " 'Female',\n",
       " 'Male',\n",
       " 'Adult',\n",
       " 'Middle Aged',\n",
       " 'Aged',\n",
       " 'Retrospective Studies',\n",
       " 'Cross-Sectional Studies',\n",
       " 'Child',\n",
       " 'Adolescent',\n",
       " 'COVID-19* / epidemiology',\n",
       " 'Animals',\n",
       " 'COVID-19 / virology',\n",
       " 'Young Adult',\n",
       " 'SARS-CoV-2*',\n",
       " 'Pandemics*',\n",
       " 'COVID-19 Vaccines',\n",
       " 'Vaccination',\n",
       " 'Surveys and Questionnaires',\n",
       " 'Communicable Disease Control',\n",
       " 'COVID-19* / prevention &amp; control',\n",
       " 'COVID-19 / epidemiology*',\n",
       " 'COVID-19 / epidemiology',\n",
       " 'Prospective Studies',\n",
       " 'Risk Factors',\n",
       " 'Aged, 80 and over',\n",
       " 'SARS-CoV-2 / immunology*',\n",
       " 'COVID-19 / prevention &amp; control*',\n",
       " 'COVID-19 / immunology*',\n",
       " 'SARS-CoV-2 / isolation &amp; purification',\n",
       " 'Cohort Studies',\n",
       " 'Health Personnel',\n",
       " 'Treatment Outcome',\n",
       " 'Pandemics / prevention &amp; control',\n",
       " 'Pregnancy',\n",
       " 'COVID-19 / immunology',\n",
       " 'United States',\n",
       " 'SARS-CoV-2 / genetics',\n",
       " 'Antibodies, Viral',\n",
       " 'Infant',\n",
       " 'COVID-19 / prevention &amp; control',\n",
       " 'Child, Preschool',\n",
       " 'United States / epidemiology',\n",
       " 'Hospitalization',\n",
       " 'COVID-19 / complications*',\n",
       " 'Mental Health',\n",
       " 'COVID-19 / diagnosis*',\n",
       " 'COVID-19* / complications',\n",
       " 'COVID-19 Vaccines*',\n",
       " 'Mice',\n",
       " 'Sensitivity and Specificity',\n",
       " 'Telemedicine*',\n",
       " 'SARS-CoV-2 / genetics*',\n",
       " 'COVID-19 Testing',\n",
       " 'SARS-CoV-2 / pathogenicity',\n",
       " 'SARS-CoV-2 / immunology',\n",
       " 'COVID-19 / diagnosis',\n",
       " 'Intensive Care Units',\n",
       " 'Hospitals',\n",
       " 'Severity of Illness Index',\n",
       " 'COVID-19* / drug therapy',\n",
       " 'Incidence',\n",
       " 'Infant, Newborn',\n",
       " 'Prevalence',\n",
       " 'China / epidemiology',\n",
       " 'Mutation',\n",
       " 'Longitudinal Studies',\n",
       " 'Delivery of Health Care',\n",
       " 'COVID-19 / drug therapy*',\n",
       " 'Prognosis',\n",
       " 'Disease Outbreaks',\n",
       " 'COVID-19 Vaccines / immunology*',\n",
       " 'Anxiety / epidemiology',\n",
       " 'Public Health',\n",
       " 'COVID-19 / psychology*',\n",
       " 'Reproducibility of Results',\n",
       " 'Students',\n",
       " 'COVID-19 / pathology',\n",
       " 'COVID-19 / complications',\n",
       " 'Depression / epidemiology',\n",
       " 'COVID-19* / diagnosis',\n",
       " 'Spike Glycoprotein, Coronavirus / immunology',\n",
       " 'Spike Glycoprotein, Coronavirus / genetics',\n",
       " 'Quality of Life',\n",
       " 'COVID-19 / virology*',\n",
       " 'SARS-CoV-2 / physiology',\n",
       " 'Pandemics* / prevention &amp; control',\n",
       " 'COVID-19 / mortality',\n",
       " 'Time Factors',\n",
       " 'Vaccines*',\n",
       " 'SARS-CoV-2 / drug effects*',\n",
       " 'China',\n",
       " 'COVID-19',\n",
       " 'Case-Control Studies',\n",
       " 'SARS-CoV-2 / isolation &amp; purification*',\n",
       " 'Protein Binding',\n",
       " 'Comorbidity',\n",
       " 'mRNA Vaccines',\n",
       " 'RNA, Viral',\n",
       " 'Qualitative Research',\n",
       " 'Antibodies, Viral / immunology',\n",
       " 'BNT162 Vaccine',\n",
       " 'Vaccination Hesitancy',\n",
       " 'RNA, Viral / genetics',\n",
       " 'COVID-19 / transmission',\n",
       " 'COVID-19 / drug therapy',\n",
       " 'COVID-19 / therapy',\n",
       " 'Vero Cells',\n",
       " 'Spike Glycoprotein, Coronavirus',\n",
       " 'Chlorocebus aethiops',\n",
       " 'COVID-19* / therapy',\n",
       " 'Vaccines, Synthetic',\n",
       " 'Antibodies, Neutralizing / immunology',\n",
       " 'Social Media*',\n",
       " 'HEK293 Cells',\n",
       " 'COVID-19 / therapy*',\n",
       " 'COVID-19 / mortality*',\n",
       " 'Antibodies, Viral / blood',\n",
       " 'Antibodies, Neutralizing',\n",
       " 'Follow-Up Studies',\n",
       " 'Antibodies, Viral / immunology*',\n",
       " 'Tomography, X-Ray Computed',\n",
       " 'COVID-19 / metabolism',\n",
       " 'COVID-19 / blood',\n",
       " 'Spike Glycoprotein, Coronavirus / immunology*',\n",
       " 'Health Knowledge, Attitudes, Practice',\n",
       " 'Antiviral Agents / therapeutic use',\n",
       " 'Antiviral Agents / pharmacology',\n",
       " 'Phylogeny',\n",
       " 'COVID-19 / blood*',\n",
       " 'Spike Glycoprotein, Coronavirus / metabolism',\n",
       " 'SARS-CoV-2 / metabolism',\n",
       " 'Italy / epidemiology',\n",
       " 'Schools',\n",
       " 'Cell Line',\n",
       " 'Age Factors',\n",
       " 'SARS-CoV-2 / metabolism*',\n",
       " 'Respiration, Artificial',\n",
       " 'COVID-19 Vaccines / adverse effects',\n",
       " 'COVID-19 Vaccines / administration &amp; dosage',\n",
       " 'Algorithms',\n",
       " 'SARS-CoV-2 / drug effects',\n",
       " 'Primary Health Care',\n",
       " 'Molecular Docking Simulation',\n",
       " 'Lung',\n",
       " 'COVID-19 / pathology*',\n",
       " 'SARS-CoV-2* / genetics',\n",
       " 'COVID-19 Vaccines / administration &amp; dosage*',\n",
       " 'Antiviral Agents / pharmacology*',\n",
       " 'Antibodies, Viral / blood*',\n",
       " 'Tertiary Care Centers',\n",
       " 'Students, Medical*',\n",
       " 'Seroepidemiologic Studies',\n",
       " 'Hospital Mortality',\n",
       " 'Brazil / epidemiology',\n",
       " 'Angiotensin-Converting Enzyme 2 / metabolism',\n",
       " 'Adaptation, Psychological',\n",
       " 'Anxiety',\n",
       " 'SARS-CoV-2 / physiology*',\n",
       " 'Masks',\n",
       " 'Exercise',\n",
       " 'Deep Learning*',\n",
       " 'Quarantine',\n",
       " 'COVID-19 / genetics*',\n",
       " 'Seasons',\n",
       " 'Physical Distancing',\n",
       " 'Models, Theoretical',\n",
       " 'Environmental Monitoring',\n",
       " 'COVID-19 Vaccines / immunology',\n",
       " 'Vaccination / adverse effects',\n",
       " 'United Kingdom',\n",
       " 'Mental Health*',\n",
       " 'COVID-19 / physiopathology',\n",
       " 'COVID-19 / genetics',\n",
       " 'Biomarkers',\n",
       " 'Binding Sites',\n",
       " 'United Kingdom / epidemiology',\n",
       " 'Spike Glycoprotein, Coronavirus / chemistry',\n",
       " 'Japan / epidemiology',\n",
       " 'Inflammation',\n",
       " 'Immunoglobulin G / blood',\n",
       " 'Disease Models, Animal',\n",
       " 'Critical Illness',\n",
       " 'Communication',\n",
       " 'COVID-19 / metabolism*',\n",
       " 'Viral Load',\n",
       " 'India / epidemiology',\n",
       " 'Databases, Factual',\n",
       " 'Critical Care',\n",
       " 'Artificial Intelligence',\n",
       " 'Vaccine Efficacy',\n",
       " 'SARS-CoV-2 / pathogenicity*',\n",
       " 'Republic of Korea / epidemiology',\n",
       " 'Randomized Controlled Trials as Topic',\n",
       " 'Pilot Projects',\n",
       " 'Immunoglobulin G',\n",
       " 'Immunization, Passive',\n",
       " 'Education, Distance*',\n",
       " 'Depression',\n",
       " 'Brazil',\n",
       " 'Attitude',\n",
       " 'Antibody Formation',\n",
       " 'Antibodies, Neutralizing / immunology*',\n",
       " 'Students, Nursing*',\n",
       " 'Intention',\n",
       " 'Influenza, Human* / epidemiology',\n",
       " 'India',\n",
       " 'COVID-19* / immunology',\n",
       " 'COVID-19 Vaccines / adverse effects*',\n",
       " 'COVID-19 / transmission*',\n",
       " 'Biosensing Techniques*',\n",
       " 'Angiotensin-Converting Enzyme 2 / genetics',\n",
       " 'Air Pollutants* / analysis',\n",
       " 'Universities',\n",
       " 'Sex Factors',\n",
       " 'RNA, Messenger',\n",
       " 'Psychological Distress*',\n",
       " 'Molecular Dynamics Simulation',\n",
       " 'Lung / diagnostic imaging',\n",
       " 'Immunogenicity, Vaccine',\n",
       " 'Host-Pathogen Interactions',\n",
       " 'Ethnicity',\n",
       " 'Spike Glycoprotein, Coronavirus / genetics*',\n",
       " 'Spain / epidemiology',\n",
       " 'Policy',\n",
       " 'Perception',\n",
       " 'Particulate Matter / analysis',\n",
       " 'Neural Networks, Computer',\n",
       " 'Immunity, Innate',\n",
       " 'Emotions',\n",
       " 'Canada',\n",
       " 'Australia / epidemiology',\n",
       " 'Parents',\n",
       " 'Oxygen Saturation',\n",
       " 'Minority Groups',\n",
       " 'Hospitalization / statistics &amp; numerical data*',\n",
       " 'Global Health',\n",
       " 'Antibodies, Neutralizing / blood',\n",
       " 'Transplant Recipients',\n",
       " 'South Africa',\n",
       " 'Saudi Arabia / epidemiology',\n",
       " 'Risk Assessment',\n",
       " 'Mice, Inbred C57BL',\n",
       " 'Machine Learning',\n",
       " 'Lung / virology',\n",
       " 'Internet',\n",
       " 'Emergency Service, Hospital',\n",
       " 'COVID-19 Nucleic Acid Testing',\n",
       " 'Antiviral Agents / therapeutic use*',\n",
       " 'Antiviral Agents / chemistry',\n",
       " 'Stress, Psychological / epidemiology',\n",
       " 'SARS-CoV-2 / classification',\n",
       " 'Neoplasms* / epidemiology',\n",
       " 'Mice, Inbred BALB C',\n",
       " 'Epidemics*',\n",
       " 'Disease Outbreaks / prevention &amp; control',\n",
       " 'COVID-19 / physiopathology*',\n",
       " 'Biomarkers / blood',\n",
       " 'Angiotensin-Converting Enzyme 2 / metabolism*',\n",
       " 'Virus Internalization',\n",
       " 'ROC Curve',\n",
       " 'Physicians*',\n",
       " 'Pandemics / prevention &amp; control*',\n",
       " 'Logistic Models',\n",
       " 'Length of Stay',\n",
       " 'Health Services Accessibility',\n",
       " 'Forecasting',\n",
       " 'Disease Progression',\n",
       " 'Diagnostic Tests, Routine',\n",
       " 'Cytokines / metabolism',\n",
       " 'ChAdOx1 nCoV-19',\n",
       " 'Bangladesh / epidemiology',\n",
       " 'Australia',\n",
       " 'Air Pollution* / analysis',\n",
       " 'Trust',\n",
       " 'Spike Glycoprotein, Coronavirus / metabolism*',\n",
       " 'Sociodemographic Factors',\n",
       " 'Research Design',\n",
       " 'Registries',\n",
       " 'Real-Time Polymerase Chain Reaction',\n",
       " 'Pharmaceutical Preparations*',\n",
       " 'Personal Protective Equipment',\n",
       " 'Nursing Homes',\n",
       " 'Neutralization Tests',\n",
       " 'Mice, Transgenic',\n",
       " 'Italy',\n",
       " 'HIV Infections* / epidemiology',\n",
       " 'Government',\n",
       " 'Double-Blind Method',\n",
       " 'Cells, Cultured',\n",
       " 'COVID-19* / mortality',\n",
       " 'Bayes Theorem',\n",
       " 'Vaccine Development',\n",
       " 'South Africa / epidemiology',\n",
       " 'Socioeconomic Factors',\n",
       " 'Referral and Consultation',\n",
       " 'RNA, Messenger / genetics',\n",
       " 'Outpatients',\n",
       " 'Nasopharynx / virology',\n",
       " 'Motivation',\n",
       " 'Models, Biological',\n",
       " 'Immunization, Secondary',\n",
       " 'Immunity, Humoral',\n",
       " 'Health Policy',\n",
       " 'Fear',\n",
       " 'Ethnic and Racial Minorities',\n",
       " 'Computer Simulation',\n",
       " 'Cities',\n",
       " 'BNT162 Vaccine*',\n",
       " 'Anxiety / psychology',\n",
       " 'Waste Water',\n",
       " 'Vaccination / methods',\n",
       " 'Turkey / epidemiology',\n",
       " 'Technology',\n",
       " 'Spike Glycoprotein, Coronavirus / chemistry*',\n",
       " 'Reverse Transcriptase Polymerase Chain Reaction',\n",
       " 'Quality of Life*',\n",
       " 'Protein Domains',\n",
       " 'Pregnant Women',\n",
       " 'Polymerase Chain Reaction',\n",
       " 'Odds Ratio',\n",
       " 'Nurses*',\n",
       " 'Mexico / epidemiology',\n",
       " 'Influenza, Human* / prevention &amp; control',\n",
       " 'Influenza Vaccines*',\n",
       " 'Immunoglobulin G / immunology',\n",
       " 'Immunity',\n",
       " 'Hospitalization / statistics &amp; numerical data',\n",
       " 'Europe / epidemiology',\n",
       " 'Epidemiological Models',\n",
       " 'Ecosystem',\n",
       " 'Developing Countries',\n",
       " 'Cytokines / blood',\n",
       " 'Cricetinae',\n",
       " 'Computational Biology',\n",
       " 'Chronic Disease',\n",
       " 'Caregivers',\n",
       " 'Canada / epidemiology',\n",
       " 'COVID-19* / psychology',\n",
       " 'COVID-19* / genetics',\n",
       " 'COVID-19 Vaccines / therapeutic use',\n",
       " 'COVID-19 Serological Testing / methods*',\n",
       " 'COVID-19 Nucleic Acid Testing / methods*',\n",
       " 'BNT162 Vaccine / immunology*',\n",
       " 'Antibodies, Monoclonal, Humanized',\n",
       " 'Ventilators, Mechanical',\n",
       " 'State Medicine',\n",
       " 'Social Isolation',\n",
       " 'Sleep Quality',\n",
       " 'Self Report',\n",
       " 'RNA, Viral / genetics*',\n",
       " 'Quarantine*',\n",
       " 'Nigeria',\n",
       " 'Neoplasms* / therapy',\n",
       " 'Mortality',\n",
       " 'Magnetic Resonance Imaging',\n",
       " 'Kinetics',\n",
       " 'Internship and Residency*',\n",
       " 'Homeless Persons*',\n",
       " 'Germany',\n",
       " 'Genome, Viral / genetics',\n",
       " 'France / epidemiology',\n",
       " 'Feasibility Studies',\n",
       " 'Curriculum',\n",
       " 'Communicable Disease Control / methods',\n",
       " 'COVID-19 Testing*',\n",
       " 'Angiotensin-Converting Enzyme 2',\n",
       " 'World Health Organization',\n",
       " 'Uncertainty',\n",
       " 'Stroke Volume',\n",
       " 'Severity of Illness Index*',\n",
       " 'Saudi Arabia',\n",
       " 'Patient Discharge',\n",
       " 'Patient Acuity',\n",
       " 'Lung / pathology',\n",
       " 'Laboratories',\n",
       " 'Iran / epidemiology',\n",
       " 'Iran',\n",
       " 'Interleukin-6 / blood',\n",
       " 'Infectious Disease Transmission, Vertical',\n",
       " 'Health Services',\n",
       " 'Health Personnel*',\n",
       " 'Health Knowledge, Attitudes, Practice*',\n",
       " 'HIV Infections* / complications',\n",
       " 'Genome, Viral',\n",
       " 'Depression / psychology',\n",
       " 'Contact Tracing',\n",
       " 'COVID-19* / veterinary',\n",
       " 'C-Reactive Protein / analysis',\n",
       " 'Burnout, Professional* / epidemiology',\n",
       " 'Autopsy',\n",
       " 'Angiotensin-Converting Enzyme 2 / chemistry',\n",
       " 'Ventricular Function, Left',\n",
       " 'Vaccination / statistics &amp; numerical data*',\n",
       " 'Systemic Inflammatory Response Syndrome',\n",
       " 'Sleep',\n",
       " 'Signal Transduction',\n",
       " 'Risk',\n",
       " 'Rats',\n",
       " 'Proportional Hazards Models',\n",
       " 'Opioid-Related Disorders* / drug therapy',\n",
       " 'New York City / epidemiology',\n",
       " 'Loneliness',\n",
       " 'Learning',\n",
       " 'Leadership',\n",
       " 'Japan',\n",
       " 'Israel / epidemiology',\n",
       " 'Inpatients',\n",
       " 'Human Rights',\n",
       " 'Germany / epidemiology',\n",
       " 'Genomics',\n",
       " 'Genome, Viral*',\n",
       " 'COVID-19* / virology',\n",
       " 'COVID-19* / physiopathology',\n",
       " 'COVID-19* / diagnostic imaging',\n",
       " 'COVID-19 Vaccines / genetics',\n",
       " 'COVID-19 Testing / methods*',\n",
       " 'Amino Acid Sequence',\n",
       " 'Vaccination / statistics &amp; numerical data',\n",
       " 'Telemedicine* / methods',\n",
       " 'Sweden / epidemiology',\n",
       " 'Survivors',\n",
       " 'Specimen Handling',\n",
       " 'Social Determinants of Health',\n",
       " 'Predictive Value of Tests',\n",
       " 'Phosphoproteins / immunology',\n",
       " 'Models, Statistical',\n",
       " 'Masks*',\n",
       " 'Limit of Detection',\n",
       " 'Life Style',\n",
       " 'Kidney Transplantation* / adverse effects',\n",
       " 'Immunoassay',\n",
       " 'Immunization',\n",
       " 'Hospitalization*',\n",
       " 'Health Status',\n",
       " 'HIV Infections* / drug therapy',\n",
       " 'Genotype',\n",
       " 'Gene Expression Profiling',\n",
       " 'Gene Expression',\n",
       " 'England / epidemiology',\n",
       " 'Education, Nursing, Baccalaureate*',\n",
       " 'COVID-19 / etiology',\n",
       " 'CD8-Positive T-Lymphocytes / immunology',\n",
       " 'BNT162 Vaccine / immunology',\n",
       " 'BNT162 Vaccine / administration &amp; dosage*',\n",
       " 'Antibodies, Neutralizing / blood*',\n",
       " 'Antibodies, Monoclonal, Humanized / therapeutic use*',\n",
       " 'Alanine / analogs &amp; derivatives*',\n",
       " 'Age Distribution',\n",
       " 'Aerosols',\n",
       " 'Adenosine Monophosphate / analogs &amp; derivatives*',\n",
       " 'Vaccine Efficacy*',\n",
       " 'Travel',\n",
       " 'Temperature',\n",
       " 'Switzerland / epidemiology',\n",
       " 'Stress Disorders, Post-Traumatic* / epidemiology',\n",
       " 'Social Support',\n",
       " 'Smartphone',\n",
       " 'Sentiment Analysis',\n",
       " 'SARS-CoV-2* / immunology',\n",
       " 'SARS-CoV-2 / chemistry*',\n",
       " 'Rural Population',\n",
       " 'Resilience, Psychological*',\n",
       " 'RNA, Viral / metabolism',\n",
       " 'Quality Improvement',\n",
       " 'Public Health*',\n",
       " 'Proteomics',\n",
       " 'Protein Interaction Domains and Motifs',\n",
       " 'Point-of-Care Systems',\n",
       " 'Physical Distancing*',\n",
       " 'Personal Satisfaction',\n",
       " 'Patient Satisfaction',\n",
       " 'Pakistan / epidemiology',\n",
       " 'Outcome Assessment, Health Care',\n",
       " 'Nasopharynx',\n",
       " 'Multivariate Analysis',\n",
       " 'Mothers',\n",
       " 'Models, Molecular',\n",
       " 'Mobile Applications*',\n",
       " 'Microbial Sensitivity Tests',\n",
       " 'Liposomes',\n",
       " 'Israel',\n",
       " 'Immunogenicity, Vaccine*',\n",
       " 'Health Personnel / psychology*',\n",
       " 'Europe',\n",
       " 'Dogs',\n",
       " 'Cystic Fibrosis* / therapy',\n",
       " 'Communicable Diseases* / epidemiology',\n",
       " 'Communicable Diseases*',\n",
       " 'Cluster Analysis',\n",
       " 'Cause of Death',\n",
       " 'COVID-19 / psychology',\n",
       " 'Biomarkers / blood*',\n",
       " 'BNT162 Vaccine / adverse effects*',\n",
       " 'BNT162 Vaccine / administration &amp; dosage',\n",
       " 'mRNA Vaccines / immunology',\n",
       " 'Water Pollutants, Chemical* / analysis',\n",
       " 'Virus Replication / drug effects',\n",
       " 'Turkey',\n",
       " 'Triage',\n",
       " 'Transcriptome',\n",
       " 'Telemedicine* / organization &amp; administration',\n",
       " 'T-Lymphocytes / immunology',\n",
       " 'Systematic Reviews as Topic',\n",
       " 'Swine',\n",
       " 'Substance-Related Disorders* / epidemiology',\n",
       " 'Republic of Korea',\n",
       " 'Renal Dialysis',\n",
       " 'Psychiatry*',\n",
       " 'Poland / epidemiology',\n",
       " 'Phosphoproteins / genetics',\n",
       " 'Patient Safety',\n",
       " 'Oxygen',\n",
       " 'Oxidative Stress',\n",
       " 'Observational Studies as Topic',\n",
       " 'Nucleic Acid Amplification Techniques',\n",
       " 'Mutation*',\n",
       " 'Multicenter Studies as Topic',\n",
       " 'Mucormycosis* / diagnosis',\n",
       " 'Models, Theoretical*',\n",
       " 'Midwifery*',\n",
       " 'Medicare',\n",
       " 'Lung / immunology',\n",
       " 'Immunoglobulin G / blood*',\n",
       " 'Immunocompromised Host',\n",
       " 'Immunity, Humoral / immunology',\n",
       " 'Hospitals, University',\n",
       " 'Hospitals, Public',\n",
       " 'Hospital Mortality*',\n",
       " 'High-Throughput Nucleotide Sequencing',\n",
       " 'Health Promotion',\n",
       " 'Family Characteristics',\n",
       " 'Enzyme-Linked Immunosorbent Assay',\n",
       " 'Education, Medical*',\n",
       " 'Early Detection of Cancer',\n",
       " 'Drug Combinations',\n",
       " 'Diagnosis, Differential',\n",
       " 'Cross Infection* / epidemiology',\n",
       " 'Consensus',\n",
       " 'Clinical Competence',\n",
       " 'Cell Line, Tumor',\n",
       " 'COVID-19 / diagnostic imaging*',\n",
       " 'Breast Neoplasms* / epidemiology',\n",
       " 'Body Mass Index',\n",
       " 'Bias',\n",
       " 'Attitude of Health Personnel',\n",
       " 'Antifungal Agents / therapeutic use',\n",
       " 'Antibodies, Monoclonal / therapeutic use',\n",
       " 'Anti-Bacterial Agents / therapeutic use',\n",
       " 'Alanine / analogs &amp; derivatives',\n",
       " 'Aging',\n",
       " 'Administration, Oral',\n",
       " 'Adenosine Monophosphate / analogs &amp; derivatives',\n",
       " 'A549 Cells',\n",
       " 'Workplace',\n",
       " 'Vulnerable Populations',\n",
       " 'Virulence',\n",
       " 'Vaccination / psychology*',\n",
       " 'Survival Analysis',\n",
       " 'Stress, Psychological',\n",
       " 'Sexual and Gender Minorities*',\n",
       " 'Screen Time',\n",
       " 'Saliva / virology*',\n",
       " 'SARS-CoV-2* / isolation &amp; purification',\n",
       " 'RNA, Viral*',\n",
       " 'Public Policy',\n",
       " 'Positron Emission Tomography Computed Tomography',\n",
       " 'Plastics',\n",
       " 'Phenotype',\n",
       " 'Opiate Substitution Treatment',\n",
       " 'Ontario / epidemiology',\n",
       " 'New York City',\n",
       " 'Macaca mulatta',\n",
       " 'Lymphocyte Count',\n",
       " 'Language',\n",
       " 'Infodemic',\n",
       " 'Immunoglobulin M / blood',\n",
       " 'Immunoglobulin M',\n",
       " 'Immunoglobulin G / immunology*',\n",
       " 'Immunization, Secondary*',\n",
       " 'Immunity, Cellular',\n",
       " 'Hypertension* / epidemiology',\n",
       " 'Hong Kong / epidemiology',\n",
       " 'Health Personnel / statistics &amp; numerical data*',\n",
       " 'Health Facilities',\n",
       " 'Geography',\n",
       " 'Gene Expression Regulation',\n",
       " 'Epitopes',\n",
       " 'Epidemiological Monitoring',\n",
       " 'Electronic Nicotine Delivery Systems*',\n",
       " 'Electronic Health Records',\n",
       " 'Drug Repositioning',\n",
       " 'Disinfection',\n",
       " 'Diagnostic Tests, Routine / methods*',\n",
       " 'Diabetes Mellitus, Type 2* / epidemiology',\n",
       " 'Dexamethasone / therapeutic use',\n",
       " 'Denmark / epidemiology',\n",
       " 'Decision Making',\n",
       " 'Cytokines / blood*',\n",
       " 'Cytokine Release Syndrome',\n",
       " 'Cystic Fibrosis* / epidemiology',\n",
       " 'Cost-Benefit Analysis',\n",
       " 'Coronavirus Nucleocapsid Proteins / genetics',\n",
       " 'Coinfection*',\n",
       " 'Cognition',\n",
       " 'Clinical Trials as Topic',\n",
       " 'Cesarean Section',\n",
       " 'COVID-19* / transmission',\n",
       " 'COVID-19* / metabolism',\n",
       " 'COVID-19 Vaccines* / adverse effects',\n",
       " 'COVID-19 Vaccines / therapeutic use*',\n",
       " 'CD8-Positive T-Lymphocytes / immunology*',\n",
       " 'Asthma* / epidemiology',\n",
       " 'Anxiety / etiology',\n",
       " 'Antigens, Viral / immunology*',\n",
       " 'Anticoagulants / therapeutic use',\n",
       " 'Angiotensin-Converting Enzyme 2 / immunology',\n",
       " 'Anatomy* / education',\n",
       " 'Ambulatory Care Facilities',\n",
       " 'Acute Disease',\n",
       " 'Zika Virus*',\n",
       " 'X-Rays',\n",
       " 'Workforce',\n",
       " 'Whole Genome Sequencing',\n",
       " 'Virus Shedding',\n",
       " 'Virus Replication*',\n",
       " 'Vaccines, Inactivated',\n",
       " 'Vaccination Hesitancy / psychology',\n",
       " 'Vaccination Coverage',\n",
       " 'Universities*',\n",
       " 'Uganda / epidemiology',\n",
       " 'Texas',\n",
       " 'T-Lymphocytes / immunology*',\n",
       " 'Switzerland',\n",
       " 'Sweden',\n",
       " 'Suicidal Ideation',\n",
       " 'Structure-Activity Relationship',\n",
       " 'Spain',\n",
       " 'Seroconversion',\n",
       " 'Schools, Medical',\n",
       " 'Schools*',\n",
       " 'Saliva',\n",
       " 'SARS-CoV-2 / growth &amp; development',\n",
       " 'SARS-CoV-2 / chemistry',\n",
       " 'Robotics*',\n",
       " 'Rheumatic Diseases* / drug therapy',\n",
       " 'Research',\n",
       " 'Renin-Angiotensin System',\n",
       " 'Remote Consultation*',\n",
       " 'Regression Analysis',\n",
       " 'Quality of Health Care',\n",
       " 'Public Opinion',\n",
       " 'Psychometrics',\n",
       " 'Psychological Distress',\n",
       " 'Pregnancy Complications, Infectious*',\n",
       " 'Poverty',\n",
       " 'Patient Acuity*',\n",
       " 'Patient Acceptance of Health Care',\n",
       " 'Palliative Care',\n",
       " 'Organ Transplantation*',\n",
       " 'Occupational Health*',\n",
       " 'Neoplasms* / complications',\n",
       " 'Nanoparticles',\n",
       " 'Mucormycosis* / epidemiology',\n",
       " 'Molecular Diagnostic Techniques',\n",
       " 'Models, Statistical*',\n",
       " 'Meta-Analysis as Topic',\n",
       " 'Mass Screening',\n",
       " 'Lung / metabolism',\n",
       " 'Long-Term Care',\n",
       " 'Ligands',\n",
       " 'Latin America / epidemiology',\n",
       " 'Interrupted Time Series Analysis',\n",
       " 'Inflammation / pathology',\n",
       " 'Infection Control',\n",
       " 'Immunoglobulin A / immunology',\n",
       " 'Immunity, Humoral*',\n",
       " 'Hispanic or Latino',\n",
       " 'Health Status Disparities',\n",
       " 'Health Behavior',\n",
       " 'Graphite*',\n",
       " 'Global Health*',\n",
       " 'Ghana / epidemiology',\n",
       " 'Food Assistance*',\n",
       " 'Fluorodeoxyglucose F18',\n",
       " 'Fibrin Fibrinogen Degradation Products / analysis',\n",
       " 'Fatigue / etiology',\n",
       " 'Evolution, Molecular*',\n",
       " 'Empathy',\n",
       " 'Emergency Medical Services*',\n",
       " 'Emergencies',\n",
       " 'Education, Nursing*',\n",
       " 'Diabetes Mellitus*',\n",
       " 'Dentists',\n",
       " 'Dental Care',\n",
       " 'Cross Reactions / immunology',\n",
       " 'Coronavirus Nucleocapsid Proteins / immunology*',\n",
       " 'Coronavirus 3C Proteases / antagonists &amp; inhibitors*',\n",
       " 'Communicable Disease Control*',\n",
       " 'Communicable Disease Control / methods*',\n",
       " 'COVID-19* / pathology',\n",
       " 'COVID-19 Serological Testing*',\n",
       " 'C-Reactive Protein / metabolism',\n",
       " 'Buprenorphine* / therapeutic use',\n",
       " 'Breast Neoplasms* / therapy',\n",
       " 'Breast Feeding',\n",
       " 'Blood Coagulation',\n",
       " 'BNT162 Vaccine / adverse effects',\n",
       " 'Asthma* / drug therapy',\n",
       " 'Artificial Intelligence*',\n",
       " 'Anxiety Disorders',\n",
       " 'Antiviral Agents / adverse effects',\n",
       " 'Antiviral Agents',\n",
       " 'Antigens, Viral',\n",
       " 'Antibodies, Monoclonal / immunology',\n",
       " 'Administration, Intranasal',\n",
       " '2019-nCoV Vaccine mRNA-1273 / adverse effects',\n",
       " '2019-nCoV Vaccine mRNA-1273',\n",
       " 'mRNA Vaccines / adverse effects*',\n",
       " 'Zika Virus Infection*',\n",
       " 'Wearable Electronic Devices*',\n",
       " 'Virtual Reality*',\n",
       " 'Viral Proteins / genetics',\n",
       " 'Vaccines, Synthetic / adverse effects*',\n",
       " 'Vaccination*',\n",
       " 'Vaccination Hesitancy / statistics &amp; numerical data',\n",
       " 'Tomography, X-Ray Computed / methods',\n",
       " 'Time-to-Treatment',\n",
       " 'Thrombosis*',\n",
       " 'Thrombosis / etiology*',\n",
       " 'Telemedicine* / standards',\n",
       " 'Telemedicine',\n",
       " 'Systemic Racism',\n",
       " 'Syndrome',\n",
       " 'Survival Rate',\n",
       " 'Suicidal Ideation*',\n",
       " 'Stroke* / epidemiology',\n",
       " 'Spike Glycoprotein, Coronavirus* / genetics',\n",
       " 'Spatial Analysis',\n",
       " 'Serologic Tests',\n",
       " 'Serine Endopeptidases / metabolism*',\n",
       " 'Sequence Alignment',\n",
       " 'Scotland / epidemiology',\n",
       " 'SARS-CoV-2 / enzymology',\n",
       " 'Respiratory Tract Infections* / epidemiology',\n",
       " 'Respiratory Aerosols and Droplets',\n",
       " 'Renal Dialysis / adverse effects',\n",
       " 'Reference Standards',\n",
       " 'Recombinant Proteins / immunology',\n",
       " 'Real-Time Polymerase Chain Reaction / methods*',\n",
       " 'RNA, Viral / analysis',\n",
       " 'Protein Domains / genetics',\n",
       " 'Protein Conformation',\n",
       " 'Protective Factors',\n",
       " 'Protease Inhibitors / pharmacology*',\n",
       " 'Premature Birth* / epidemiology',\n",
       " 'Pregnancy Complications, Infectious* / epidemiology',\n",
       " 'Pregnancy Complications, Infectious / epidemiology*',\n",
       " 'Point-of-Care Testing',\n",
       " 'Pharmaceutical Preparations',\n",
       " 'Personal Protective Equipment*',\n",
       " 'Patient Discharge*',\n",
       " 'Patient Care',\n",
       " 'Parturition',\n",
       " 'Opioid-Related Disorders* / epidemiology',\n",
       " 'Nigeria / epidemiology',\n",
       " 'Netherlands / epidemiology',\n",
       " 'Netherlands',\n",
       " 'Neoplasms* / drug therapy',\n",
       " 'Needs Assessment',\n",
       " 'Nasopharynx / virology*',\n",
       " 'Nanoparticles*',\n",
       " 'Mucormycosis* / drug therapy',\n",
       " 'Morals',\n",
       " 'Molecular Diagnostic Techniques / methods',\n",
       " 'Mexico',\n",
       " 'Mental Disorders* / epidemiology',\n",
       " 'Leukocytes, Mononuclear / immunology',\n",
       " 'Length of Stay / statistics &amp; numerical data',\n",
       " 'L-Lactate Dehydrogenase / blood',\n",
       " 'Kidney Transplantation*',\n",
       " 'Kenya / epidemiology',\n",
       " 'Intensive Care Units / statistics &amp; numerical data',\n",
       " 'Influenza A Virus, H1N1 Subtype*',\n",
       " 'Inflammation / immunology',\n",
       " 'Immunologic Memory',\n",
       " 'Immunoglobulin M / immunology',\n",
       " 'Immunoassay / methods',\n",
       " 'Immunization Schedule',\n",
       " 'Immunity, Innate*',\n",
       " 'Immune System',\n",
       " 'Hypertension* / drug therapy',\n",
       " 'Host-Pathogen Interactions / immunology',\n",
       " 'Host-Pathogen Interactions / genetics',\n",
       " 'Heart Failure* / epidemiology',\n",
       " 'Health Services Accessibility*',\n",
       " 'Health Personnel / psychology',\n",
       " 'Health Behavior*',\n",
       " 'HIV Infections* / prevention &amp; control',\n",
       " 'HIV Infections*',\n",
       " 'Gene Regulatory Networks',\n",
       " 'France',\n",
       " 'Food Supply',\n",
       " 'Fibrin Fibrinogen Degradation Products',\n",
       " 'Fever / etiology',\n",
       " 'Fatal Outcome',\n",
       " 'Faculty, Nursing',\n",
       " 'Evolution, Molecular',\n",
       " 'Ethiopia / epidemiology',\n",
       " 'Ethiopia',\n",
       " 'Epitopes, T-Lymphocyte / immunology',\n",
       " 'England',\n",
       " 'Employment',\n",
       " 'Emergency Service, Hospital*',\n",
       " 'Electrochemical Techniques',\n",
       " 'Electrocardiography',\n",
       " 'Drug Repositioning*',\n",
       " 'Drug Evaluation, Preclinical',\n",
       " 'Drug Design',\n",
       " 'Dose-Response Relationship, Drug',\n",
       " 'Disinformation',\n",
       " 'Disinfectants*',\n",
       " 'Disease Transmission, Infectious / prevention &amp; control*',\n",
       " 'Disabled Persons*',\n",
       " 'Diabetes Mellitus, Type 2* / complications',\n",
       " 'Depression / diagnosis',\n",
       " 'Cytokine Release Syndrome / immunology',\n",
       " 'Cytokine Release Syndrome / drug therapy*',\n",
       " 'Cystic Fibrosis* / psychology',\n",
       " 'Crystallography, X-Ray',\n",
       " 'Cross Reactions',\n",
       " 'Critical Care / statistics &amp; numerical data',\n",
       " 'Coronavirus Nucleocapsid Proteins / immunology',\n",
       " 'Computers',\n",
       " 'ChAdOx1 nCoV-19 / administration &amp; dosage*',\n",
       " 'ChAdOx1 nCoV-19 / administration &amp; dosage',\n",
       " 'Cardiovascular Diseases / complications',\n",
       " 'COVID-19* / blood',\n",
       " 'COVID-19 Vaccines* / immunology',\n",
       " 'CD4-Positive T-Lymphocytes / immunology*',\n",
       " 'CD4-Positive T-Lymphocytes / immunology',\n",
       " 'Biomarkers / metabolism',\n",
       " 'Basic Reproduction Number',\n",
       " 'Base Sequence',\n",
       " 'B-Lymphocytes / immunology',\n",
       " 'Area Under Curve',\n",
       " 'Antiviral Agents / administration &amp; dosage',\n",
       " 'Anticoagulants',\n",
       " 'Antibodies, Viral / biosynthesis',\n",
       " 'Antibodies, Viral / analysis*',\n",
       " 'Antibodies, Monoclonal',\n",
       " 'Angiotensin-Converting Enzyme 2 / genetics*',\n",
       " 'Angiotensin-Converting Enzyme 2 / chemistry*',\n",
       " 'Ambulatory Care',\n",
       " 'Africa / epidemiology',\n",
       " 'Adsorption',\n",
       " 'Acute Kidney Injury* / epidemiology',\n",
       " '2019-nCoV Vaccine mRNA-1273 / immunology*',\n",
       " '2019-nCoV Vaccine mRNA-1273 / administration &amp; dosage',\n",
       " 'mRNA Vaccines / immunology*',\n",
       " 'Viruses*',\n",
       " 'Viruses / classification',\n",
       " 'Virus Replication / drug effects*',\n",
       " 'Virus Internalization*',\n",
       " 'Virus Diseases*',\n",
       " 'Videoconferencing',\n",
       " 'Veterans*',\n",
       " 'Vaccines, Synthetic / immunology',\n",
       " 'Vaccines, Subunit / immunology',\n",
       " 'Vaccine Efficacy / statistics &amp; numerical data*',\n",
       " 'Vaccination Hesitancy / trends*',\n",
       " 'Vaccination Hesitancy / statistics &amp; numerical data*',\n",
       " 'Vaccination Hesitancy / psychology*',\n",
       " 'Vaccination / psychology',\n",
       " 'Vaccination / methods*',\n",
       " 'Vaccination / adverse effects*',\n",
       " 'Urban Population',\n",
       " 'Ultrasonography',\n",
       " 'Trauma Centers',\n",
       " 'Transients and Migrants*',\n",
       " 'Thorax',\n",
       " 'Telephone',\n",
       " 'Teaching',\n",
       " 'T-Lymphocytes',\n",
       " 'Students / psychology',\n",
       " 'Stress Disorders, Post-Traumatic / epidemiology*',\n",
       " 'Steroids / therapeutic use',\n",
       " 'Spirituality',\n",
       " 'Spike Glycoprotein, Coronavirus* / metabolism',\n",
       " 'Spike Glycoprotein, Coronavirus*',\n",
       " 'Speech',\n",
       " 'Specimen Handling / methods*',\n",
       " 'Specimen Handling / methods',\n",
       " 'Spatio-Temporal Analysis',\n",
       " 'Social Networking',\n",
       " 'Social Behavior*',\n",
       " 'Smell',\n",
       " 'Single-Blind Method',\n",
       " 'Singapore / epidemiology',\n",
       " 'Signal Transduction / drug effects',\n",
       " 'Serine Endopeptidases / genetics',\n",
       " 'Self Efficacy',\n",
       " 'Search Engine',\n",
       " 'Reverse Transcription',\n",
       " 'Respiratory Syncytial Virus Infections* / epidemiology',\n",
       " 'Respiratory Insufficiency* / therapy',\n",
       " 'Respiratory Distress Syndrome* / therapy',\n",
       " 'Respiration, Artificial / statistics &amp; numerical data',\n",
       " 'Recombinant Proteins / metabolism',\n",
       " 'Recombinant Proteins / genetics',\n",
       " 'Recombinant Proteins / chemistry',\n",
       " 'Receptors, Virus / metabolism',\n",
       " 'Reagent Kits, Diagnostic',\n",
       " 'Radiology*',\n",
       " 'Radiography, Thoracic',\n",
       " 'Quarantine / psychology',\n",
       " 'Propensity Score',\n",
       " 'Prone Position',\n",
       " 'Probability',\n",
       " 'Pregnancy Outcome',\n",
       " 'Postpartum Period',\n",
       " 'Positron-Emission Tomography',\n",
       " 'Politics',\n",
       " 'Poland',\n",
       " 'Point-of-Care Testing*',\n",
       " 'Point-of-Care Systems*',\n",
       " 'Pneumonia* / diagnosis',\n",
       " 'Peru',\n",
       " 'Personnel, Hospital',\n",
       " 'Percutaneous Coronary Intervention*',\n",
       " 'Pakistan',\n",
       " 'Pain',\n",
       " 'Organizational Innovation',\n",
       " 'Ontario',\n",
       " 'Obesity / epidemiology',\n",
       " 'Obesity / complications',\n",
       " 'Nucleic Acid Conformation',\n",
       " 'Nucleic Acid Amplification Techniques / methods*',\n",
       " 'Norway / epidemiology',\n",
       " 'New Zealand / epidemiology',\n",
       " 'New York / epidemiology',\n",
       " 'Neutrophils / immunology',\n",
       " 'Neutralization Tests / methods',\n",
       " 'Neoplasms / therapy*',\n",
       " 'Myocarditis* / etiology',\n",
       " 'Multiple Sclerosis* / epidemiology',\n",
       " 'Multiple Sclerosis* / drug therapy',\n",
       " 'Monocytes / immunology',\n",
       " 'Monitoring, Physiologic',\n",
       " 'Molecular Structure',\n",
       " 'Molecular Dynamics Simulation*',\n",
       " 'Molecular Docking Simulation*',\n",
       " 'Microfluidics',\n",
       " 'MicroRNAs / genetics*',\n",
       " 'Mice, Knockout',\n",
       " 'Mesocricetus',\n",
       " 'Mental Disorders* / therapy',\n",
       " 'Medicine, Chinese Traditional',\n",
       " 'Maternal Health Services*',\n",
       " 'Mass Vaccination',\n",
       " 'Lung Neoplasms* / epidemiology',\n",
       " 'Lung / metabolism*',\n",
       " 'Lung / drug effects',\n",
       " 'Lung / diagnostic imaging*',\n",
       " 'Long-Term Care*',\n",
       " 'Leukocytes, Mononuclear',\n",
       " 'Kidney',\n",
       " 'Kenya',\n",
       " 'Jordan',\n",
       " 'Job Satisfaction',\n",
       " 'Intravitreal Injections',\n",
       " 'Intimate Partner Violence*',\n",
       " 'Interleukin-6 / genetics',\n",
       " 'Insurance, Health',\n",
       " 'Influenza, Human / virology',\n",
       " 'Indonesia / epidemiology',\n",
       " 'Indonesia',\n",
       " 'Income',\n",
       " 'Immunotherapy',\n",
       " 'Immunosuppressive Agents / adverse effects',\n",
       " 'Immunophenotyping',\n",
       " 'Immunization Programs',\n",
       " 'Immune Evasion',\n",
       " 'Hydrogen-Ion Concentration',\n",
       " 'House Calls',\n",
       " 'Hospitals, General',\n",
       " 'Hospitals*',\n",
       " 'Hospitalization / trends',\n",
       " 'Hong Kong',\n",
       " 'Homosexuality, Male',\n",
       " 'Heart Rate',\n",
       " 'Heart Failure* / therapy',\n",
       " 'Health Personnel* / psychology',\n",
       " 'Health Personnel / statistics &amp; numerical data',\n",
       " 'Hand Hygiene*',\n",
       " 'Hand Disinfection',\n",
       " ...]"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vocab"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "996af1b1",
   "metadata": {},
   "source": [
    "## Finding good value for max length (using median value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "8f85ca6d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    4925.000000\n",
       "mean      148.807513\n",
       "std        49.753408\n",
       "min        23.000000\n",
       "25%       117.000000\n",
       "50%       147.000000\n",
       "75%       177.000000\n",
       "max       436.000000\n",
       "Name: abstract, dtype: float64"
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_df[\"abstract\"].apply(lambda x: len(x.split(\" \"))).describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "14009b3d",
   "metadata": {},
   "source": [
    "## Transforming datasets to later vectorise"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "4648895e",
   "metadata": {},
   "outputs": [],
   "source": [
    "max_seqlen = 150\n",
    "batch_size = 128\n",
    "padding_token = \"<pad>\"\n",
    "auto = tf.data.AUTOTUNE\n",
    "\n",
    "\n",
    "def make_dataset(dataframe, is_train=True):\n",
    "    labels = tf.ragged.constant(dataframe[\"tags\"].values)\n",
    "    label_binarized = lookup(labels).numpy()\n",
    "    dataset = tf.data.Dataset.from_tensor_slices(\n",
    "        (dataframe[\"abstract\"].values, label_binarized)\n",
    "    )\n",
    "    dataset = dataset.shuffle(batch_size * 10) if is_train else dataset\n",
    "    return dataset.batch(batch_size)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "829ff898",
   "metadata": {},
   "outputs": [],
   "source": [
    "train_dataset = make_dataset(train_df, is_train=True)\n",
    "validation_dataset = make_dataset(val_df, is_train=False)\n",
    "test_dataset = make_dataset(test_df, is_train=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "c73d75a9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<BatchDataset element_spec=(TensorSpec(shape=(None,), dtype=tf.string, name=None), TensorSpec(shape=(None, 10519), dtype=tf.float32, name=None))>"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_dataset"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c7a58156",
   "metadata": {},
   "source": [
    "## Creating vocabulary for vectorisation of text and mapping dataset with vectorizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "4f38e20c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "45816\n"
     ]
    }
   ],
   "source": [
    "vocabulary = set()\n",
    "train_df[\"abstract\"].str.lower().str.split().apply(vocabulary.update)\n",
    "vocabulary_size = len(vocabulary)\n",
    "print(vocabulary_size)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "74fcb82b",
   "metadata": {},
   "outputs": [],
   "source": [
    "text_vectorizer = layers.TextVectorization(\n",
    "    max_tokens=vocabulary_size, ngrams=2, output_mode=\"tf_idf\"\n",
    ")\n",
    "\n",
    "# `TextVectorization` layer needs to be adapted as per the vocabulary from our\n",
    "# training set.\n",
    "with tf.device(\"/CPU:0\"):\n",
    "    text_vectorizer.adapt(train_dataset.map(lambda text, label: text))\n",
    "\n",
    "train_dataset = train_dataset.map(\n",
    "    lambda text, label: (text_vectorizer(text), label), num_parallel_calls=auto\n",
    ").prefetch(auto)\n",
    "validation_dataset = validation_dataset.map(\n",
    "    lambda text, label: (text_vectorizer(text), label), num_parallel_calls=auto\n",
    ").prefetch(auto)\n",
    "test_dataset = test_dataset.map(\n",
    "    lambda text, label: (text_vectorizer(text), label), num_parallel_calls=auto\n",
    ").prefetch(auto)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "83b7c13c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<bound method DatasetV2.cardinality of <PrefetchDataset element_spec=(TensorSpec(shape=(None, 45816), dtype=tf.float32, name=None), TensorSpec(shape=(None, 10519), dtype=tf.float32, name=None))>>"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_dataset.cardinality"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "85fe360c",
   "metadata": {},
   "source": [
    "## Dataset now ready to be used"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "d04c8a8e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<PrefetchDataset element_spec=(TensorSpec(shape=(None, 45816), dtype=tf.float32, name=None), TensorSpec(shape=(None, 10519), dtype=tf.float32, name=None))>"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_dataset"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a8df9d13",
   "metadata": {},
   "source": [
    "## Creating the model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "4da7c163",
   "metadata": {},
   "outputs": [],
   "source": [
    "def make_model():\n",
    "    shallow_mlp_model = keras.Sequential(\n",
    "        [\n",
    "            layers.Dense(512, activation=\"relu\"),\n",
    "            layers.Dense(256, activation=\"relu\"),\n",
    "            layers.Dense(128, activation=\"relu\"),\n",
    "            layers.Dense(lookup.vocabulary_size(), activation=\"sigmoid\"),\n",
    "        ] \n",
    "    )\n",
    "    return shallow_mlp_model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "e48d0d0c",
   "metadata": {},
   "outputs": [],
   "source": [
    "epochs = 15\n",
    "\n",
    "shallow_mlp_model = make_model()\n",
    "shallow_mlp_model.compile(\n",
    "    loss= \"poisson\", optimizer = keras.optimizers.Adam(learning_rate=0.00005), metrics=[\"categorical_accuracy\"], \n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2dfbe196",
   "metadata": {},
   "source": [
    "## Training the model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "4a70a2c4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 1/15\n",
      "39/39 [==============================] - 8s 181ms/step - loss: 0.4207 - categorical_accuracy: 0.0000e+00 - val_loss: 0.2587 - val_categorical_accuracy: 0.0000e+00\n",
      "Epoch 2/15\n",
      "39/39 [==============================] - 7s 173ms/step - loss: 0.1247 - categorical_accuracy: 0.4504 - val_loss: 0.0261 - val_categorical_accuracy: 0.4343\n",
      "Epoch 3/15\n",
      "39/39 [==============================] - 7s 179ms/step - loss: 0.0162 - categorical_accuracy: 0.9840 - val_loss: 0.0106 - val_categorical_accuracy: 0.4343\n",
      "Epoch 4/15\n",
      "39/39 [==============================] - 8s 189ms/step - loss: 0.0097 - categorical_accuracy: 0.9840 - val_loss: 0.0088 - val_categorical_accuracy: 0.4343\n",
      "Epoch 5/15\n",
      "39/39 [==============================] - 7s 173ms/step - loss: 0.0085 - categorical_accuracy: 0.9840 - val_loss: 0.0081 - val_categorical_accuracy: 0.4343\n",
      "Epoch 6/15\n",
      "39/39 [==============================] - 8s 205ms/step - loss: 0.0080 - categorical_accuracy: 0.9840 - val_loss: 0.0077 - val_categorical_accuracy: 0.4343\n",
      "Epoch 7/15\n",
      "39/39 [==============================] - 7s 171ms/step - loss: 0.0077 - categorical_accuracy: 0.9840 - val_loss: 0.0075 - val_categorical_accuracy: 0.4343\n",
      "Epoch 8/15\n",
      "39/39 [==============================] - 8s 207ms/step - loss: 0.0076 - categorical_accuracy: 0.9840 - val_loss: 0.0074 - val_categorical_accuracy: 0.4343\n",
      "Epoch 9/15\n",
      "39/39 [==============================] - 7s 171ms/step - loss: 0.0075 - categorical_accuracy: 0.9840 - val_loss: 0.0073 - val_categorical_accuracy: 0.4343\n",
      "Epoch 10/15\n",
      "39/39 [==============================] - 8s 203ms/step - loss: 0.0074 - categorical_accuracy: 0.9840 - val_loss: 0.0073 - val_categorical_accuracy: 0.4343\n",
      "Epoch 11/15\n",
      "39/39 [==============================] - 7s 169ms/step - loss: 0.0073 - categorical_accuracy: 0.9840 - val_loss: 0.0072 - val_categorical_accuracy: 0.4343\n",
      "Epoch 12/15\n",
      "39/39 [==============================] - 8s 199ms/step - loss: 0.0073 - categorical_accuracy: 0.9840 - val_loss: 0.0072 - val_categorical_accuracy: 0.4343\n",
      "Epoch 13/15\n",
      "39/39 [==============================] - 7s 181ms/step - loss: 0.0072 - categorical_accuracy: 0.9840 - val_loss: 0.0072 - val_categorical_accuracy: 0.4343\n",
      "Epoch 14/15\n",
      "39/39 [==============================] - 8s 205ms/step - loss: 0.0072 - categorical_accuracy: 0.9840 - val_loss: 0.0072 - val_categorical_accuracy: 0.4343\n",
      "Epoch 15/15\n",
      "39/39 [==============================] - 8s 193ms/step - loss: 0.0071 - categorical_accuracy: 0.9840 - val_loss: 0.0072 - val_categorical_accuracy: 0.4343\n"
     ]
    }
   ],
   "source": [
    "history = shallow_mlp_model.fit(\n",
    "    train_dataset, validation_data=validation_dataset, epochs=epochs\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da2819be",
   "metadata": {},
   "source": [
    "## Visuallising our training"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "id": "0fda2818",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAZsAAAEXCAYAAAB76ulbAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjQuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/MnkTPAAAACXBIWXMAAAsTAAALEwEAmpwYAAA9HUlEQVR4nO3deXxU1f3/8dcnYYewCIgICqggsgUImwsKIopL3XGtdflaaysutbbqD1v0Z9tfq9atbnWhlBa/qFhxKS5VwQ1QFjGBILJLwhaWbEDI9vn9cW/iMMwkM8lc7tzk83w85pHcudt7Zu69Z+69Z84RVcUYY4zxUorfAYwxxjR8VtgYY4zxnBU2xhhjPGeFjTHGGM9ZYWOMMcZzVtgYY4zxXKAKGxGZJiLv+J0jGhFZLiL3e7yOMSKiItIp0nCUeS4VkXrXcY9lXSY6EdkgInclcHlJvT+YYPJqP/eksHGD1vSYVsdF3w78OIFRDxkR+ZWIFIhIqwjjUkVks4j8oQ6Lng90BXbWO+SBmSIdGD1ZV6IlcaE4HHjG7xDGISJnichH7n65T0S+EZHbRcS3L+HufhfpmPknvzIlildvateQx08jPHd76MQi0jSWhapqgarmJy7mITUdaAFMjDDubOAIYGq8C1XVUlXdqofg17mHcl0NiYg0A1DVPFXd63eeZFH1vvi07p8Dc4AlwMlAP5wvAg8ALx+C9dd0zPu/HHi87Ar83utMnlNVTx/Apc5qqod7AgpcCXwM7AMmAR2B/wVy3OdWANeHLWsa8E7I8DycDeSPwA5gO/AIkFJDnljWU+tygcOBN91lbARuAJYD99ew7teATyI8/wbwsfv/nUAmsAfIBV4E2odMO8Z9/zpFGnaf+4mbaS/wDnBL2GdwrJt9q7uepcB5Ya9fQx81rOtiIAvYD2wCJgMSMn4DcB/wN6DQfd9/HcN2cy7wpfv+7gTeBlq4434MLAKK3M/mNaBb2PYV+pjmjhPgN8Bad7lZwI/D1jvSfT9KgK+Bc9xljAmZ5lQ3WwmwDXgMaBb2/j3rbjN5wKKQ9+KukOnautNtcZe1Erg8ju10GiH7Qy3v5wTgM2A3sAt4HzghbJojgRnu+70XWAaMjfEzOeC1hbwPT4VtC/fjfKnKB15zn/8TsMpd7gbgoarl1rZu4HfA8giv9wvgySjvRXec7fXxCOMudD/vie7wAuAvYdO0dXNc5A43A/7sflZ7cLbNsyLss+cAXwGlhOxvYcs+6H0MG1+1rPPcz6cEp8DMCJuutv2yGc7xbaM7zTrgtrB1jHPf873AYmBoyPztgH/i7H8l7vx31LgNxrKh1udB9MJmgzuul/vhdwN+DQwGjgFucj+UcdF2LpyNuQDnm0Af4DKgHLiyhjyxrKfW5eJ8K1qB861oiDtPMTUXNhPc135cyHNdgDLganf4DuB09306Dafg+WeEjS1iYYNzsKx0N64+wM9wds7QzyAduBkYCBznTlsK9HXHH4azgT6Ac8Z1RJR1ZQAV7nR9gKvd9+DWsJ1nJ84XiuOAW91lnFjL+1SO822uHzAIuAto5Y6/AWfHPQYYAcwFPnXHpeLsaOrOewTQzh33B5yD2gSc7e4qnIPDue74NjiFw8tAf2C8+xlXFzY4288e4DngBJydfishByR3WygC/gL0xT2oE3IgwSn4vgCy3TzH4JzhXhSynrj2h1r2w0vcR2/3/XwVWINbSAKtgdVuplNxvpBcjFvYxPCZVL+2sPchvLApxCnwjwN6u8//Fmc/6ul+rt8DD8ayPeAcO8qBESHTH+9+ZulR3otfuuOPjDL+O+AN9/9bcL70hX7RvB6nwK5672YAC9337Ricbb20av38sN9kAWe603SOsu6D3sew8VXL+hY4CxiA82Vra8hnEct+WfVF5hI3z1jgJ2Hr+Mp9vi/Ol5OVuAUW8Fecwm6E+7mNwS2go2aPZUOtz4Pohc2vYph3JvBitJ0LZ2NeEDbPf0PniTFj+HpqXK77ASpwcsj4Hu4HXFNhk4LzTeKPIc/92t1wW0SZZwLON4+UsA0hWmHzMvDfsGW8GPoZRFnPQuC+mjb6COuagXtGFjLN/UBO2HL+N2ya1aHripDlC2BmHJ9fXzdX90g53eda43wbHR027+PAHPf/n7mfRcuQ8VdxYGHzB5yDdOjB5zr3M6ra2ecBmRFyVr+nOAVZJWFnF/XZH+Lc5lu72+sp7vBPcQrITlGmr/EzibK9zOPgwubtGLLdDKyJY93vAM+FDP8ZWFzD9M8CBTWMfxPIdv/vyMGF/IfA39z/j3U/x6PDljEbeCZse7wkhte+wd2WisMe54Ut6+qQedrgnCne6A7XuF/ifOFQYEKUDFXrCD07O5kD97G3gL/Hs835WRttceiAe5N8sohkishOESnG+WZ1dC3LyQwb3oxziSuiONZT03JPwNnAvqoaqaob3WmiUtVKnAPEtSKS6j59PTBDVUvcfKeLyH9FJEdEioB/45zyHlHTskOcgHPqH+qAYRFpLSIPiUi2iOx234Nh1P5eR1rXF2HPfQ50E5G2Ic/F9RnhnCl+FG2kiAwVkTdFZKP7HlVtSzXl74dz2eU9ESmuegA/xzlggFNoLVfVfSHzfRm2nBNwvohUhjz3Oc5ndFzIc0tqyALOa9yiqisjjazH/hCRiBwrIi+LyFoRKcS5/JcSsrwhOAXkjhryRv1M4rA4/Am3tuTnIrLVfZ2PceDrrG3dLwBXiEhLd7+6BniplhxawzipGq+qO3G+1V/tZu2K823/X+60Q93ps8O2q3P5YbuqctBrj+JRnDPa0MfcsGmq92lVLcY5a+rnPlXbfjkE5/gVvsxwoftt1bGtar99FrjMrVTxiIicVsuyaFLbBB7aEzZ8F/ArnMoDWTil+R+p+aAEziWoUErNFR9iXU9Ny5VaMtVkKs49jLNEJB9nw7gKQER6AP/B2Xl+h3P5aSjOKW+sN1NjyfYIzhnTXThnGXtxKjDEe8O2eqeMIPT5eD+j6CsUaY2z83+Ic1DZDnTCuR9RU/6q9f0I5zJNqKp8Nb0eYpgm9Pnw7TvScmpS1/0hmrdxLgf9zP1bjnMJr+o9q882Dc7BK3wZkW6CH/C+iMgonDO2B3Aub+UD5+Nso7H6D842fAnO5e/2OPtMNN8B7USkm6rmRhh/As7l0yr/Ap4XkV/g3GvehHPwBme7UpyahuHb+b6w4dq2iSo7VXVNjNNGUts2GutnHfp6qpaXAqCq77rHq7Nx7u38R0ReU9Xroy0smX5ncwrOKfY/VXUZzk3cPkm6npU4793wqidE5GicG6w1cs+APgT+x30scXOAc3bRDPilqi5Q1e9iWWaYbGBU2HPhw6cA01X1dVXNxLl2G/4trBTn/kdt6zolwrJzVLUo9sgH+RpnA46kL07h8n9U9VNV/ZaDD8Cl7t/Q/Nk4lyd6qOqasMdGd5qVwEARaRky34iwZWcDJ4ZVjz3FXefaWF6caynQVUROiDI+YfuDiHTEOYD+UVU/dM+m0jjwy+ZSYFAN1cVr+kzAudfVNWSdLXA+q9qcDOSq6oOqukhVV+Ncko553apajnPF4Ab38W+tudbqLJwD6a/DR4jIRThnqDNCnn7T/XsezhnODHWvJbnZBOe+Zvh2FakgS5Tqfdr9AjYAZ/uF2vfLpTjHr7H1CaCqO9zt8zqcY9m1ItI82vTJVNh8B4wTkVNEpC/wFM5N3KRbj6quAt4D/iYiJ4rIYJyNPfybTDQv4XzDvpwDT/dX43wmd4hILxG5EqfCQDyeBM4QkXtFpLeI/BS4KGya74CL3MtRA3G+ubUIm2YDMFpEutVwAPoLcJqI3C8ifUTkapxv4w/FmTncH4CJIvJ7EeknIv1F5Jfub5S+xyk0JonIMSJyLvBg2Pwbcb6JnSsinUWkjbuTPQI8IiI3iMhxIjJYRG4WkZvc+Wbg3Md4wV3vGcD/ccdVHVyewfkC8IyInOCu/0849ybiqdb8Ec4lutfF+b1HLxEZLyIXuuMTuT/sxqlV+VP3dZ+GU8GhPGSal3HOEmeLyGg3z/kiUnVAqukzAadm6dXi/MapP84ZfCw/afgO5/LO1e7n+XOcs4dQta0bnPuSp+EUCDVeQlPVTTjb6a3u5eT+7uu9Cfg78IqqvhYyfQnO5ez7cK40/Ctk3Hc4280093LgMSIyTETuEpGLY3j9kaSJyBFhj3Zh09znbi9V73UpP1TZrnG/dAv0V4EXReQS97WPFpFrYg0oIv9XRC50jzEn4FziXaeq+6POFM8Nnro8iF5BYFjYdB1wPtCq6qwP4ezY80KmmcbBFQSeClvOAdNEyBPLempdLk4tsrdwCphNwI3UUvU5ZN5mON8E9+LWlAoZdxvOZY59OAeky9z3q6ceePOupqrP1+MclPcB7+LUjgn9DHrgnF3twTmruQvnJuu0kGlGAd/gVGvUGtZVVcWylOhVn2u8cRzlPTof577HfpwD5Vv8UM32cpxv+iU4983O4uDqyb/FqVJcyYFVn2/lh7OcPJyKH+PDXvfX7vivcS7NKDAyZJqqqs/7+aHqc/PaXl/4e4FzuecFN0eJm+uyuu4Ptbyfp+NsnyXu37NwLs1dFzJNd+AVnEtZe93XPybGz6QtzqWrApzt9xfh70OkbcF9/v+570Gx+5p/TliFlprWHTLNx+52ITG+J+fg3Lcoct+XTJzLlgf9dMJ9/xTnSkT4uKY4N+DX4ewHW918GdH2mxoybeDgqvsK/CtsWee7effjnKkMD1tObftlc3ebynWXsRaYVMN+3pOQ47a7vBXudrILp3ZujZVdqqqxGWMiEJELcH4HdbhGv3lukoCIZONc4qpLSxyBICJjcArIzkHbHv2sIGBM0hGRa3G+oW7CuQ7+OM69k0Dt2I2JiByOc+mtJ86Ph00SssLGmAN1wakZ1RXncsh/gLt9TVQLt3JKdg2T9FPV8Bp4Dck2nEtrP7MvBcnLLqMZE3Ai0gTnW300G9SpsWWMb6ywMcYY47lAXkbr1KmT9uzZs07z7tmzh9atWyc2kIeClDdIWSFYeYOUFYKVN0hZoX55lyxZskNVOyc4UmxiqSKYbI+MjAytq7lz59Z5Xj8EKW+QsqoGK2+QsqoGK2+QsqrWLy81tBnn9SOZftRpjDGmgbLCxhhjjOc8LWxEZKqIbBeR5VHGi4g8KSJrxGnddqiXeYwxxvjD6zObaTitC0dzNk7fCr1xOod61uM8xhhjfOBpYaOqn+K0mxPNBTitD6uqLgTai9NfhDHGmAbE89/ZiEhPnMYCB0QY9w7wJ1X93B3+CLhbVSN1sHQTztkPXbp0yZg5c2ad8hQXF9OmTZs6zeuHIOUNUlYIVt4gZYVg5Q1SVqhf3rFjxy5R1WEJjhQbr6u74fyyeXmUcf/B7ZbWHf4It6XUmh5W9Tk5BSmrarDyBimrarDyBimranCrPvv9o84c4KiQ4e7U0rVyY/JO5mY+WF3K0tJVfkeJyYaNwckKwcobpKwQrLxBygrQdk8FY/wOUQd+FzZv4XSCNRMYCRSo6hafMyWFkrIK7pi5jPJKRdbVp4fYQ0iBoGSFYOUNUlYIVt4gZQWuOD7e3tuTg6eFjYj8L05HPJ1EJAeYgtt7n6o+h9PhzjnAGpxOeKL2X93YZG8ppLxSuXVIc351+Rl+x4nJvHnzGDNmjN8xYhakvEHKCsHKG6Ss4OQNIk8LG1UN7941fLwCt3iZIaiW5xYA0Kud/e7WGBN8diRLUpk5BXRq05wOzcXvKMYYU29W2CSprJwCBnVvh4gVNsaY4LPCJgntLS1n9fYiBnRr53cUY4xJCCtsklD25kIqFQZZYWOMaSCssElCmTlO5YCB3a2wMcY0DFbYJKGs3AK6tG1Ol7Yt/I5ijDEJYYVNEsrMyWdgt/Z+xzDGmISxwibJFJWUsW7HHgbZJTRjTANihU2SWbG5EFW7X2OMaVissEkyWVWVA6wmmjGmAbHCJslk5hbQrX1LOrVp7ncUY4xJGCtskszy3AI7qzHGNDhW2CSRgn1lrN+xx+7XGGMaHCtsksgKt6Vnq4lmjGlorLBJIpluYTPgSCtsjDENixU2SSQrp4CjDmtJh9bB7InPGGOiscImiWTm5jPIWg4wxjRAVtgkid17Stm0a59VDjDGNEhW2CSJrKrKAVbt2RjTAFlhkySqCpv+VtgYYxogK2ySRGZOPr06taZdy6Z+RzHGmISzwiZJZOVYywHGmIbLCpskkFe0n80FJfZjTmNMg2WFTRJYnmstPRtjGjYrbJJAVm4BIlY5wBjTcFlhkwQycwo4tnMb2jRv4ncUY4zxhBU2SSArN98uoRljGjQrbHy2rbCEbYX7rbAxxjRoVtj4rKobaKuJZoxpyKyw8VlmbgEpAv2ObOt3FGOM8YwVNj7Lysmn9+FptGpmlQOMMQ2X54WNiEwQkVUiskZE7okwvp2IvC0i34jIChG53utMyUJVycotsJaejTENnqeFjYikAk8DZwP9gCtFpF/YZLcA2aqaDowB/iIijaL3sC0FJewoLrX7NcaYBs/rM5sRwBpVXaeqpcBM4IKwaRRIExEB2gC7gHKPcyWFzBxrOcAY0ziIqnq3cJFLgQmqeqM7fA0wUlUnhUyTBrwF9AXSgMtV9T8RlnUTcBNAly5dMmbOnFmnTMXFxbRp06ZO8ybarO9KeXd9Gc+e0YpmqRJxmmTKW5sgZYVg5Q1SVghW3iBlhfrlHTt27BJVHZbgSLFRVc8ewETgxZDha4C/hk1zKfAYIMBxwHqgbU3LzcjI0LqaO3dunedNtB+/uFDPfvzTGqdJpry1CVJW1WDlDVJW1WDlDVJW1frlBRarh8f8mh5eX0bLAY4KGe4ObA6b5nrg3+57scYtbPp6nMt3qsry3AK7X2OMaRS8LmwWAb1FpJd70/8KnEtmob4HxgGISBfgeGCdx7l8l7N7H7v3lllNNGNMo+DpjztUtVxEJgHvA6nAVFVdISI3u+OfAx4EpolIFs6ltLtVdYeXuZJBlnUrYIxpRDz/JaGqzgHmhD33XMj/m4Ezvc6RbDJzCmiaKhx/RJrfUYwxxnPWgoBPsnLz6XtEW5o3SfU7ijHGeM4KGx+oKpk51nKAMabxsMLGBxt37qWopJxBdr/GGNNIWGHjg8yqygF2ZmOMaSSssPFBVk4+zZqk0KeLVQ4wxjQOVtj4IDOngH5d29I01d5+Y0zjEPPRTkQGeBmksaistJYDjDGNTzxfrZ8Tka9E5Bci0t6rQA3duh172FNaYT/mNMY0KjEXNqp6CnA1Tltni0XkZREZ71myBmq5WzlgUPf2/gYxxphDKK6bBqq6GrgPuBs4DXhSRL4VkYu9CNcQZeYU0LJpKsd2bu13FGOMOWTiuWczSEQeA1YCpwM/UtUT3P8f8yhfg5OVm0+/I9vSxCoHGGMakXiOeE8BS4F0Vb1FVZdCddtm93kRrqGpqFSW5xba/RpjTKMTT0Oc5wD7VLUCQERSgBaquldV/+lJugZmbV4x+8oqrCaaMabRiefM5kOgZchwK/c5E6PMnKrKAVbYGGMal3gKmxaqWlw14P7fKvGRGq6snHxaN0ulV6fg9HdujDGJEE9hs0dEhlYNiEgGsC/xkRquzNwC+ndrR2qK+B3FGGMOqXju2dwBvCYim93hrsDlCU/UQJVVVJK9uZBrRvXwO4oxxhxyMRc2qrpIRPoCx+N03/ytqpZ5lqyBWb2tmP3lldbSszGmUYq3W+jjgX5AC2CIiKCq0xMfq+HJys0HrOUAY0zjFHNhIyJTgDE4hc0c4Gzgc8AKmxhk5hSQ1qIJPQ6zOhXGmMYnngoClwLjgK2qej2QDjT3JFUDtDy3gIHd2pFilQOMMY1QPIXNPlWtBMpFpC2wHTjGm1gNS2l5JSu3FNn9GmNMoxXPPZvFbtcCLwBLgGLgKy9CNTTfbSuitKLSmqkxxjRaMRU2IiLA/1PVfJx+bd4D2qpqppfhGorqlgO6tfc3iDHG+CSmy2iqqsDskOENVtDELis3n3Ytm3LUYS1rn9gYYxqgeO7ZLBSR4Z4lacAyc5xuoJ0TRGOMaXziKWzGAgtEZK2IZIpIlojY2U0tSsoqWLW1yO7XGGMatXgqCJztWYoG7NutRZRXqrX0bIxp1OIpbNSzFA1YVk4+AAOt5QBjTCMWT2HzH5wCR3Caq+kFrAL6e5CrwcjMKaBj62Yc2a6F31GMMcY38TTEOTB02O1u4GcJT9TAZOUWMNAqBxhjGrl4KggcQFWXArXWThORCSKySkTWiMg9UaYZIyLLRGSFiHxS10zJZl9pBd9tK2KQVQ4wxjRy8TTEeWfIYAowFMirZZ5U4GlgPJADLBKRt1Q1O2Sa9sAzwARV/V5EDo89fnLL3lJApdr9GmOMiefMJi3k0RznHs4FtcwzAlijqutUtRSYGWGeq4B/q+r3AKq6PY5MSS2rquUAq4lmjGnkxGkcwKOFi1yKc8Zyozt8DTBSVSeFTPM40BSnokEa8ESkPnJE5CbgJoAuXbpkzJw5s06ZiouLadOmTZ3mjdcLmftZvrOCJ8bWvVuBQ5m3voKUFYKVN0hZIVh5g5QV6pd37NixS1R1WIIjxUZVY3oA/wXahwx3AN6vZZ6JwIshw9cAfw2b5ilgIdAa6ASsBvrUtNyMjAytq7lz59Z53nid8Zd5esPfv6rXMg5l3voKUlbVYOUNUlbVYOUNUlbV+uUFFmuMx/xEP+K5jNZZnYY4qwqp3UBt91dygKNChrsDmyNM856q7lHVHcCnOH3lBNqe/eWsySu2bgWMMYb47tlUiMjRVQMi0oPaf+i5COgtIr1EpBlwBfBW2DRvAqNFpImItAJGAivjyJWUVmwuRNXu1xhjDMT3o87JwOchVZNPxb2HEo2qlovIJOB9IBWYqqorRORmd/xzqrrS7bIgE6jEuey2PN4Xkmwy3ZYDBli1Z2OMietHne+5P+QchdOKwC/dy161zTcHmBP23HNhww8DD8eaJQiycgvo2q4Fh6dZywHGGBPzZTQRuQgoU9V3VPVtnO6hL/QsWcBl5RRYS8/GGOOK557NFFUtqBpwKwtMSXiiBqCwpIx1O/bY/RpjjHHFU9hEmjaeez6NxvJcp0y2lgOMMcYRT2GzWEQeFZFjReQYEXkMWOJVsCCrajnALqMZY4wjnsLmVqAUeAV4DSgBbvEiVNBl5hbQvUNLDmvdzO8oxhiTFOKpjbYHiNhqsznQ8twCu19jjDEh4mn1uTPwG5w2zKrr86rq6R7kCqyCvWVs3LmXy4cfVfvExhjTSMRzGW0G8C1OD50PABtwWggwIbLcygGDurX3N4gxxiSReAqbjqr6Es5vbT5R1RtwfuBpQmTm5gNWOcAYY0LFU3W5zP27RUTOxWlQs3viIwVbVk4BPTq2ol2rpn5HMcaYpBFPYfN7EWkH/Ar4K9AW+KUnqQIsM6eAIUe39zuGMcYklZgvo7nN1BSo6nJVHauqGapa3YKziNzrTcTg2Fm8n9z8fVYTzRhjwsRzz6Y2ExO4rECqqhww0CoHGGPMARJZ2EgClxVIVS0HDOjW1uckxhiTXBJZ2NTWkVqDl5lbwDGdW5PWwioHGGNMKDuzSaCsnAIGWZVnY4w5SCILm9cSuKzA2V5UwtbCEmvp2RhjIqi16rOI/JUaLpGp6m3u3z8mMFfgVHUrYDXRjDHmYLH8zmax5ykagMycAkSgX1erHGCMMeFqLWxU9R+HIkjQZeUUcFznNrRubv3JGWNMuHhbfb4b6Ie1+nwAVSUzt4DRvTv5HcUYY5JSvK0+r8RafT7ItsL95BXtt5poxhgThbX6nACZOfkAVhPNGGOisFafEyArt4DUFLHKAcYYE4W1+pwAyzbl0/vwNrRslup3FGOMSUoxFzaq+o77bwEw1ps4wVNeUcnSjbu5eKid5BljTDTx1Eb7B3C7qua7wx2Av7j3bhqt7C2F7C0t45QjgT07Er78pqUFnizXC0HKCsHKG6SsEKy8QcoKkFKx3+8IdRLPZbRBVQUNgKruFpEhiY8ULF+t38Wfm7zAWXM+gTmJX/7JAPMTv1wvBCkrBCtvkLJCsPIGKSvAkcf+D3CW3zHiFk9hkyIiHVR1N4CIHBbn/A3SV+t28lCTr+Hok2DAxQlf/nerv6NP7z4JX64XgpQVgpU3SFkhWHmDlBVg9/ZgHnbjSf0XYL6IzHKHJwJ/SHyk4KisVHZuyKQ9hTD4Khh6TcLXsXnvPPqMGJPw5XohSFkhWHmDlBWClTdIWQH2zJvnd4Q6iaeCwHQRWQycjtOdwMWqmu1ZsgBYm1dMv9JMaAr0PMXvOMYYk7Rq/VGniLR1/x4GbAVexmlNYKv7XG3zTxCRVSKyRkTuqWG64SJSISKXxh7fX1+u38WolGzK2xwJHXr6HccYY5JWLGc2LwPnAUs4sKsBcYePiTajiKQCTwPjgRxgkYi8FX5G5E73Z+D9uNL7bNH6nUxJ/ZbUY84GafR9xxljTFSxtPp8nogIcJqqfh/n8kcAa1R1HYCIzAQuAMIvv90KvA4Mj3P5vlFVtq/L5DAKoedov+MYY0xSi6ltNFVV4I06LL8bsClkOMd9rpqIdAMuAp6rw/J9k7N7H8fuXeYM9DzZ1yzGGJPs4qmNtlBEhqtqPC09R7q2FN7r5+PA3apaITVcihKRm4CbALp06cK8OtbIKC4urvO8ob7ILWNUSjZ7mnZk0TcbQeI96YtNovIeCkHKCsHKG6SsEKy8QcoKwctbTVVjeuBc+ioH1gKZQBaQWcs8JwLvhwzfC9wbNs16nO4KNgDFwHbgwpqWm5GRoXU1d+7cOs8b6u7XlumOKUdp5awbE7K8aBKV91AIUlbVYOUNUlbVYOUNUlbV+uUFFmuMx/xEP+I5szm7DmXZIqC3iPQCcoErgKvCCrteVf+LyDTgHVWdXYd1HVJb12XSkQLoZfdrjDGmNvH8zmajiKQDVUfXz1T1m1rmKReRSTi1zFKBqaq6QkRudscH6j5Nlbyi/XQvWGK/rzHGmBjF0xDn7cBPgX+7T/1LRJ5X1b/WNJ+qziGs1bBohYyqXhdrHj8t2rCLUSkrKW11BM069Kp9BmOMaeTiuYz2P8BIVd0DICJ/Bhbg9G3TqHy1bieTUlaSesyZ9vsaY4yJQTyFjQAVIcMVRK5t1uBtWZtJJ7H7NcYYE6t4Cpu/A1+KSNXvbS4EXkp4oiRXWFJGp52L7H6NMcbEIZ4KAo+KyDzgFJwzmutV9WuvgiWrJRt2Myolm/2tjqD5YVFb6jHGGBMingoCh/HD72GqnmuqqmWJj5W8vlq/kxtSVpLaa7zdrzHGmBjF1FyNaymQB3wHrHb/Xy8iS0Ukw4twySh3TSadpYAmx9j9GmOMiVU8hc17wDmq2klVO+L8yPNV4BfAM16ESzYlZRW0377QGbDGN40xJmbxFDbDVLW6CwBV/QA4VVUXAs0TniwJff19PsNYyf6Wh4PdrzHGmJjFU9jsEpG7RaSH+/gNsNvti6bSo3xJZdH6nYxKWYn0Gm33a4wxJg7xFDZXAd2B2e7jKPe5VOCyRAdLRptWZ3K45NPM7tcYY0xc4qn6vAO4VUTaqGpx2Og1iY2VfMoqKmm9ZYFTPNv9GmOMiUvMZzYicpKIZOP2siki6SLSKCoGAKzYXMhQXUFJi87Q8Vi/4xhjTKDEcxntMeAsYCeA2+LzqV6ESkaL1u1kZMpKp9UAu19jjDFxiae5GlR1U1hvmhXRpm1oNqzOpIvkw3GNpnw1xpiEiaew2SQiJwEqIs2A24CV3sRKLpWVSvOc+c6A3a8xxpi4xXMZ7WbgFqAbkAMMxvlBZ4O3ensx6RXL2de8E3Q8zu84xhgTOPGc2RyvqleHPiEiJwNfJDZS8vlq3Q7OTMmm8ugxdr/GGGPqIJ4zm0idpDWKjtPWr15OF8mnVZ/T/I5ijDGBVOuZjYicCJwEdBaRO0NGtcX5QWeDpqo0+f5zAMT6rzHGmDqJ5TJaM6CNO21ayPOFwKVehEomm3bto19pJvtadqRlp95+xzHGmECqtbBR1U+AT0RkmqpuPASZksqX63YwOmUlZUeNpqXdrzHGmDqJp4LAXhF5GOgPtKh6UlVPT3iqJLLuuywmym4qjx/jdxRjjAmseCoIzAC+BXoBD+D02LnIg0xJJWWjU9kupZf9vsYYY+oqnsKmo6q+BJSp6ieqegMwyqNcSWF7YQnH7VvG3mYdwe7XGGNMncVzGa3M/btFRM4FNuN0OdBgfeX2X7O/20m0svs1xhhTZ/EUNr8XkXbAr3B+X9MWuMOLUMli7aoszpNdVPQd43cUY4wJtHguo00ERFWXq+pYYDxwkTexkkPleuf3NanHWOObxhhTH/EUNoNUNb9qQFV3AUMSnihJFOwto2fx1+xtehh06uN3HGOMCbR4CpsUEelQNSAihxFnFwVBsnjDTkamZLP3yFHWHpoxxtRTPIXFX4D5IjILUOAy4A+epEoC363KYpzsoqzvWL+jGGNM4MVc2KjqdBFZDJwOCHCxqmZ7lsxnFes+A6DpsXa/xhhj6ivenjqzgQZbwFTZV1pBt/yl7Gnegdadj/c7jjHGBF4892zqREQmiMgqEVkjIvdEGH+1iGS6j/kiku51ptp8vXEXI1Ky2dPV7tcYY0wieFrYiEgq8DRwNtAPuFJE+oVNth44TVUHAQ8Cz3uZKRbfrsqim+wkzX5fY4wxCeH1mc0IYI2qrlPVUmAmcEHoBKo6X1V3u4MLSYJWCcrWOPdrWva2ztKMMSYRRFW9W7jIpcAEVb3RHb4GGKmqk6JMfxfQt2r6sHE3ATcBdOnSJWPmzJl1ylRcXEybNm2iji+vVIrnPsK4Jt+w5NR/+n4Zrba8ySRIWSFYeYOUFYKVN0hZoX55x44du0RVhyU4UmxU1bMHTqsDL4YMXwP8Ncq0Y4GVOA1+1rjcjIwMrau5c+fWOH7Jhp266XfH6ObnJ9Z5HYlUW95kEqSsqsHKG6SsqsHKG6SsqvXLCyxWD4/5NT28voyWAxwVMtwdpwHPA4jIIOBF4AJV3elxphp9u3I53WUHbaz/GmOMSRivC5tFQG8R6SUizYArgLdCJxCRo4F/A9eo6nce56lVyepPAEizwsYYYxLG0+ZmVLVcRCYB7wOpwFRVXSEiN7vjnwN+B3QEnhHn/ki5+nRNsbJS6bTzK4pT29Gmc18/IhhjTIPkedtmqjoHmBP23HMh/98IHFQhwA+rthUxVLMpOHwEbVI8/wmSMcY0GnZEDZG9MovusoNWfcb4HcUYYxoUK2xC7F3l3K9p388a3zTGmESywsalqnTY/iXFqW2Rzif4HccYYxoUK2xcG3fuZXDlcnZ1Gg52v8YYYxKqwXZ+Fq/l2VmcJzvYbk3UmHoqKysjJyeHkpKShC2zXbt2rFy5MmHL81qQ8gYpK8SWt0WLFnTv3p2mTZseolS1s8LGVbxqHgCdB4zzN4gJvJycHNLS0ujZsyeSoOaOioqKSEtLS8iyDoUg5Q1SVqg9r6qyc+dOcnJy6NWr1yFMVjO7XuRqt+1LilPSkMPDG6U2Jj4lJSV07NgxYQWNMfEQETp27JjQM+tEsMIG2FZYwoDSLHZ0tPs1JjGsoDF+Ssbtz46sQNaKLI5KybMuoI0xxiNW2AAFK+cB0GWQ3a8xxhgvWGEDtNm6kKKUNJocMcDvKMYccvPmzWP+/PmHZF3nnHMO+fn5cc83bdo0Jk2K2A2WCYhGXxstf28pJ5R8w/bOGaTZ/RqTYA+8vYLszYX1Xk5FRQWpqakA9DuyLVN+1L/ey6wyb9482rRpw0knnZSwZYar6tNkzpw5tU+cxKr7ZrFjRdwa/Tu2fMVyjk7JI/WY0X5HMSahpk+fzqBBg0hPT+eaa67h7bffZuTIkQwZMoQzzjiDbdu2sWHDBp577jkee+wxBg8ezGeffUZeXh6XXHIJw4cPZ/jw4XzxxRcA5OXlMX78eIYOHcrPfvYzevTowY4dOwB49NFHGTBgAAMGDODxxx8HYMOGDZxwwgn84he/YOjQoWzatImePXtWzxOeD4iYMRbR5isuLub6669n4MCBDBo0iNdffx2A9957j6FDh5Kens6PfvQjAO6//34eeeSR6mUOGDCADRs2RHwdP//5zxk2bBj9+/dnypQp1fMsWrSIk046ifT0dEaMGEFRURGjR49m2bJl1dOcfPLJZGZmxvtxBp9fvbbV55HInjrf/McjqlPaasmmZXVeppeC1ItgkLKqepc3Ozs74cssLCyMa/rly5drnz59NC8vT1VVd+7cqbt27dLKykpVVX3hhRf0zjvvVFXVKVOm6MMPP1w975VXXqmfffaZqqpu3LhR+/btq6qqt9xyi/7xj39UVdV3331XAc3Ly9PFixfrgAEDtLi4WIuKirRfv3762Wef6fr161VEdMGCBdXL7tGjh+bl5UXMp6pRM/7973/XW265JerrjTbfb37zG7399tsPmG779u3avXt3XbdunaqqbtiwIeL70L9/f12/fn3E11GVt7y8XE877TT95ptvdP/+/dqrVy/96quvVFW1oKBAy8rKdNq0adUZVq1apfU5fqnGvi1E2g7xsafORn8ZrdXmhRRLG9ocOdDvKMYkzMcff8yll15Kp06dADjssMPIysri8ssvZ8uWLZSWlkb9wd+HH35IdnZ29XBhYSFFRUV8/vnnvPHGGwBMmDCBDh06APD5559z0UUX0bp1awAuvvhi5s+fz2WXXUaPHj0YNWpUTPnA+UFsLBnDRZvvww8/ZObMmdXTdejQgbfffptTTz21epqqddck/HW8+uqrPP/885SXl7Nlyxays7MREbp27crw4cMBaNu2LQATJ07kwQcf5OGHH2bq1Klcd911Mb2mhqZRX0bbW1pOn33L2NI+w35fYxoUVT3otxa33norkyZNIisri7/97W9Rf/RXWVnJggULWLZsGcuWLSM3N5e0tDScL8aR1xVNVQEUS754MsY6X6T1RFt3kyZNqKysrB4OXXfo61i/fj2PPPIIH330EZmZmZx77rmUlJREXW6rVq0YP348b775Jq+++ipXXXVVTK+poWnUR9gVK7M5WrYjPU/2O4oxCTVu3DheffVVdu7cCcCuXbsoKCigW7duAPzjH/+onjYtLY2ioqLq4TPPPJOnnnqqerjqfsMpp5zCq6++CsAHH3zA7t27ATj11FOZPXs2e/fuZc+ePbzxxhu1VjaIlA+ImrE20eYLfy27d+/mxBNP5JNPPmH9+vUHrLtnz54sXboUgKVLl1aPD1dYWEjr1q1p164d27Zt49133wWgb9++bN68mUWLFgFOszLl5eUA3Hjjjdx2220MHz48pjOphqhRFzY7ln8MQNfB431OYkxi9e/fn8mTJ3PaaaeRnp7OnXfeyf3338/EiRMZPXp09eUrgB/96Ee88cYb1RUEnnzySRYvXsygQYPo168fzz3ndKw7ZcoUPvjgA4YOHcq7775L165dSUtLY+jQoVx33XWMGDGCkSNHcuONN5Kenh53PiBqxtpEm+++++5j9+7dDBgwgPT0dObOnUvnzp15/vnnufjii0lPT+f6668H4JJLLmHXrl0MHjyYZ599lj59+kRcV3p6OkOGDKF///7ccMMNnHyy82W1WbNmvPLKK9x6662kp6czfvz46rOjjIwM2rZtW72uRsmvm0X1eSSqgsBHf75MC+8/UrWios7L81qQbroHKatqw64g4IWSkhItKytTVdX58+drenp61GmTIW+sDkXW3Nxc7d27t1Yk4FhjFQQCprS8kmP3fE1u+6H0tfs1xtTq+++/57LLLqOyspJmzZrxwgsv+B0pEKZPn87kyZN59NFHG/XvcxptYfPtqmwGyTZW9rzB7yjGBELv3r35+uuvfc3whz/8gddee+2A5yZOnMjkyZN9SlS7n/zkJ/zkJz/xO4bvGm1hsz3LvV8z6AyfkxhjYjV58uSkLlhMdI32nK5ZzhcU0Zr2vYb4HcUYYxq8RlnYVFQqPYqXsantEEhJ9TuOMcY0eI2ysFmzZhU92Er50d41PGiMMeYHjbKw2Zb5IQBHDLLf1xhjzKHQKAublO+/oIhWHH5cht9RjEkKbdq0SdiyZs+ezbfffpuw5dWkrt0ihLfwbLzX6GqjqSpHFy5lY5vBDLD7NcZr794DW7PqvZiWFeWQ6u6uRwyEs/9U72V6Zfbs2YwbN666QUovVPXvc6g6ffNKaD9FDV2jO7MpzN/B0WyltLvdrzEN1913380zzzxTPXz//ffzwAMPMG7cOIYOHcrAgQN58803Y17eQw89xMCBA0lPT+eee+4B4IUXXmD48OGkp6dzySWXsHfvXubPn89bb73Fb3/7WwYPHszatWtZu3YtEyZMICMjg9GjR1ef9axdu5ZRo0YxfPhwfve731WfXakqv/71rxkwYAADBw7klVdeAZxO3saOHctVV13FwIFOK+2hZ2SxZoxFtPm2bdvGRRddRHp6Ounp6dWFXaS+ea677jpmzZpVvcyqrJFex4UXXkhGRgb9+/fn+eefr54ntN+dcePGUVlZyeDBg8nLywOcRlOPO+646j6CkppfTRfU51Gf5mpmPfNb1Slt9fvl8+u8jEMpSE3ABCmrasNurmbp0qV66qmnVg+fcMIJunHjRi0oKFBV1by8PD322GOr+4Bp3bp11GXNmTNHTzzxRN2zZ4+q/tCXy44dO6qnmTx5sj755JOqqnrttdfq9OnTq8edfvrp+t1336mq6sKFC3Xs2LGqqnruuefqyy+/rKqqzz77bHWGWbNm6RlnnKHl5eW6detWPeqoo3Tz5s06d+5cbdWqVXU/NKG5480Y2ndNpPc22nyXXXaZPvbYY6rq9GWTn58ftW+ea6+9Vl977bWDskZ6HVXz7N27V/v37687duw4qN+dqmnuvffe6gzvv/++XnzxxQflV7XmanzXIX85RbSie1/vTvGN8duQIUPYvn07mzdvJi8vjw4dOtC1a1d++ctf8umnn5KSkkJubi7btm3jiCOOqHFZH374Iddffz2tWrUCfuj/Zfny5dx3333k5+dTXFzMWWedddC8xcXFzJ8/n4kTJ1Y/t3//fgAWLFjA7NmzAbjqqqu46667AKd/nCuvvJLU1FS6dOnCaaedxqJFi2jbti0jRoyI2MdNfTJGEm2+jz/+mOnTpwOQmppKu3btmD59esS+eWoS/jqefPLJ6r6CNm3axOrVq8nLy4vY784111zD1VdfzR133MHUqVMD07in54WNiEwAngBSgRdV9U9h48Udfw6wF7hOVZd6lefY/StY32oQg1IbXTlrGplLL72UWbNmsXXrVq644gpmzJhBXl4eS5YsoWnTpvTs2TOm/mJUI/fTct111zF79mzS09OZNm0a8+bNO2iayspK2rdvf0C3yLGsL5p4+8eJJWMk8cwXbd2h/eOoKqWlpRFfx7x58/jwww9ZsGABrVq1YsyYMTX2j9O9e3e6dOnCxx9/zJdffsmMGTNiek1+8/SejYikAk8DZwP9gCtFpF/YZGcDvd3HTcCzXuXZlrueHmylpJvdrzEN3xVXXMHMmTOZNWsWl156KQUFBRx++OE0bdqUuXPnsnHjxpiWc+aZZzJ16tTq+xZV/b8UFRXRtWtXysrKDjjgpaWlUVxcDDi9Vfbq1au6PTNV5ZtvvgFg1KhRvP766wAH9KZ56qmn8sorr1BRUUFeXh6ffvopI0aMSGjG2kSbb9y4cTz7rHOIqqiooLCwMGrfPD179mTJkiUAvPnmm5SVlUVcV0FBAR06dKBVq1Z8++23LFy4ECBqvzvg9I/z4x//mMsuuywwFQy8riAwAlijqutUtRSYCVwQNs0FQNUF3oVAexHp6kWYTV//F4DD+p/uxeKNSSr9+/enqKiIbt260bVrV66++moWL17MsGHDmDFjBn379o1pORMmTOD8889n2LBhDB48uLrK8IMPPsjIkSMZP378Acu64ooreOKJJxgyZAhr165lxowZvPTSS6Snp9O/f//qigmPP/44jz76KCNGjGDLli20a9cOgIsuuqj6Zvvpp5/OQw89VOulvngz1ibafE888QRz585l4MCBZGRksGLFiqh98/z0pz/lk08+YcSIEXz55ZdRz8omTJhAeXk5gwYN4re//W1199Ph/e5cfvnl1fOcf/75FBcXB+YSGoDUdMpa74WLXApMUNUb3eFrgJGqOilkmneAP6nq5+7wR8Ddqro4bFk34Zz50KVLl4zQb0KxKlj3JUfkvseekyeTkhKMy2jFxcUJ/Q2El4KUFbzL265dO4477riELjNoVWRjybt3715atmyJiDBr1ixmzZpFXfbr+grie/vNN99w77338v7770edbs2aNRQUFBzw3NixY5eo6jCvM0bi9RH34AuOEF66xTINqvo88DzAsGHDdMyYMfGnGTOGefNGcnpd5vXJvHnzqNNr9UGQsoJ3eVeuXElaWlpCl1lUVJTwZXoplrzLli1j0qRJqCrt27dn6tSpvrzGoL23DzzwAFOnTmXGjBk15m7RogVDhiRPQ8NeFzY5wFEhw92BzXWYxhjjsaysrOrfiFRp3rw5X375pSfrGz16dPX9G7/ccsstfPbZZwd0anb77bcn9eWpO++8kylTpvgdI25eFzaLgN4i0gvIBa4Argqb5i1gkojMBEYCBaq6xeNcxngqWk2iZDZw4MC4ao01BE8//XTgzmxi4eXtkbrytLBR1XIRmQS8j1P1eaqqrhCRm93xzwFzcKo9r8Gp+py8XymMiUGLFi3YuXMnHTt2DFyBY4JPVdm5cyctWrTwO8oBPL9LrqpzcAqU0OeeC/lfgVu8zmHModK9e3dycnKqmxRJhJKSkqQ7eNQkSHmDlBViy9uiRQu6d+9+iBLFJhhVsowJkKZNm0b8lXt9zJs3L6lu9tYmSHmDlBWCl7dKo2uI0xhjzKFnhY0xxhjPWWFjjDHGc562IOAVEckDYmvY6WCdgAB0/lAtSHmDlBWClTdIWSFYeYOUFeqXt4eqdk5kmFgFsrCpDxFZ7FdzDXURpLxBygrByhukrBCsvEHKCsHLW8UuoxljjPGcFTbGGGM81xgLm+drnySpBClvkLJCsPIGKSsEK2+QskLw8gKN8J6NMcaYQ68xntkYY4w5xKywMcYY47lGVdiIyAQRWSUia0TkHr/zRCMiR4nIXBFZKSIrROR2vzPFQkRSReRrt/fVpCUi7UVkloh8677HJ/qdqSYi8kt3O1guIv8rIknTaqSITBWR7SKyPOS5w0TkvyKy2v3bwc+MoaLkfdjdFjJF5A0Rae9jxGqRsoaMu0tEVEQ6+ZGtLhpNYSMiqcDTwNlAP+BKEennb6qoyoFfqeoJwCjgliTOGup2YKXfIWLwBPCeqvYF0knizCLSDbgNGKaqA3C66rjC31QHmAZMCHvuHuAjVe0NfOQOJ4tpHJz3v8AAVR0EfAfce6hDRTGNg7MiIkcB44HvD3Wg+mg0hQ0wAlijqutUtRSYCVzgc6aIVHWLqi51/y/CORh28zdVzUSkO3Au8KLfWWoiIm2BU4GXAFS1VFXzfQ1VuyZASxFpArQiiXqyVdVPgV1hT18A/MP9/x/AhYcyU00i5VXVD1S13B1ciNNbsO+ivLcAjwG/AQJVu6sxFTbdgE0hwzkk+QEcQER6AkMAb/rmTZzHcXaASp9z1OYYIA/4u3vJ70URae13qGhUNRd4BOdb7Bacnmw/8DdVrbpU9bbr/j3c5zzxuAF41+8Q0YjI+UCuqvrbn3YdNKbCJlKXiUn9zUBE2gCvA3eoaqHfeaIRkfOA7aq6xO8sMWgCDAWeVdUhwB6S6zLPAdz7HRcAvYAjgdYi8mN/UzVMIjIZ5xL2DL+zRCIirYDJwO/8zlIXjamwyQGOChnuThJdjggnIk1xCpoZqvpvv/PU4mTgfBHZgHN58nQR+Ze/kaLKAXJUtepMcRZO4ZOszgDWq2qeqpYB/wZO8jlTbbaJSFcA9+92n/PUSkSuBc4Drtbk/fHhsThfOr5x97XuwFIROcLXVDFqTIXNIqC3iPQSkWY4N1nf8jlTROJ0XP8SsFJVH/U7T21U9V5V7a6qPXHe149VNSm/favqVmCTiBzvPjUOyPYxUm2+B0aJSCt3uxhHEldocL0FXOv+fy3wpo9ZaiUiE4C7gfNVda/feaJR1SxVPVxVe7r7Wg4w1N2mk16jKWzcG4CTgPdxdtZXVXWFv6miOhm4BucMYZn7OMfvUA3IrcAMEckEBgN/9DdOdO4Z2CxgKZCFs88mTXMlIvK/wALgeBHJEZH/Af4EjBeR1Ti1pv7kZ8ZQUfI+BaQB/3X3ted8DemKkjWwrLkaY4wxnms0ZzbGGGP8Y4WNMcYYz1lhY4wxxnNW2BhjjPGcFTbGGGM8Z4WNMSFEpCKkuvmyRLYOLiI9I7Xga0xj0MTvAMYkmX2qOtjvEMY0NHZmY0wMRGSDiPxZRL5yH8e5z/cQkY/cvlA+EpGj3ee7uH2jfOM+qpqYSRWRF9z+aT4QkZbu9LeJSLa7nJk+vUxjPGOFjTEHahl2Ge3ykHGFqjoC5xfnj7vPPQVMd/tCmQE86T7/JPCJqqbjtL1W1VpFb+BpVe0P5AOXuM/fAwxxl3OzNy/NGP9YCwLGhBCRYlVtE+H5DcDpqrrObSR1q6p2FJEdQFdVLXOf36KqnUQkD+iuqvtDltET+K/bqRgicjfQVFV/LyLvAcXAbGC2qhZ7/FKNOaTszMaY2GmU/6NNE8n+kP8r+OG+6bk4PclmAEvcjtKMaTCssDEmdpeH/F3g/j+fH7ppvhr43P3/I+Dn4HRJ7vYQGpGIpABHqepcnA7o2gMHnV0ZE2T27cmYA7UUkWUhw++palX15+Yi8iXOl7Qr3eduA6aKyK9xegC93n3+duB5t6XeCpyCZ0uUdaYC/xKRdjid/D0WgK6qjYmL3bMxJgbuPZthqrrD7yzGBJFdRjPGGOM5O7MxxhjjOTuzMcYY4zkrbIwxxnjOChtjjDGes8LGGGOM56ywMcYY47n/D/M8DRyFDQlmAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "def plot_result(item):\n",
    "    plt.plot(history.history[item], label=item)\n",
    "    plt.plot(history.history[\"val_\" + item], label=\"val_\" + item)\n",
    "    plt.xlabel(\"Epochs\")\n",
    "    plt.ylabel(item)\n",
    "    plt.title(\"Train and Validation {} Over Epochs\".format(item), fontsize=14)\n",
    "    plt.legend()\n",
    "    plt.grid()\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "plot_result(\"loss\")\n",
    "plot_result(\"categorical_accuracy\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fdf8dcce",
   "metadata": {},
   "source": [
    "## Test Accuracy:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "161ec93b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3/3 [==============================] - 0s 36ms/step - loss: 0.0065 - categorical_accuracy: 0.5109\n",
      "Categorical accuracy on the test set: 51.09%.\n"
     ]
    }
   ],
   "source": [
    "_, categorical_acc = shallow_mlp_model.evaluate(test_dataset)\n",
    "print(f\"Categorical accuracy on the test set: {round(categorical_acc * 100, 2)}%.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "id": "f7c9ca68",
   "metadata": {},
   "outputs": [],
   "source": [
    "inference_dataset = make_dataset(test_df.sample(100), is_train=False)\n",
    "text_batch, label_batch = next(iter(inference_dataset))\n",
    "predicted_probabilities = model_for_inference.predict(text_batch)\n",
    "for prob in predicted_probabilities:\n",
    "    prob[prob > 0.5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "id": "f9bd0344",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([1.1708085e-10, 1.0000000e+00, 6.5043950e-01, ..., 8.4617330e-10,\n",
       "       1.0933418e-08, 3.0173343e-08], dtype=float32)"
      ]
     },
     "execution_count": 125,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "predicted_probabilities[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "2598c475",
   "metadata": {},
   "outputs": [],
   "source": [
    "top_3_labels = [\n",
    "    x for _, x in sorted(\n",
    "        zip(predicted_probabilities[i], lookup.get_vocabulary()),\n",
    "        key=lambda pair: pair[0],\n",
    "        reverse=True,\n",
    "    )\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "5cab0cd1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10519"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(top_3_labels)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "954a6b18",
   "metadata": {},
   "source": [
    "## Testing how the model tags data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "id": "4a78608e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Abstract: b'study investigate covid-19 infection people living ireland scopi seroprevalence study june julybackgroundrobust data sars-cov-2 population seroprevalence supplement surveillance data providing evidence public health action aimto conduct sars-cov-2 population-based seroprevalence survey ireland methodsusing cross-sectional study design selected population sample individual aged 12-69 year county dublin sligo using health service executive primary care reimbursement service database sampling frame sample selected probability proportional general population age-sex distribution simple random sampling within age-sex stratum antibody sars-cov-2 detected using abbott architect sars-cov-2 igg assay confirmed using wantai assay estimated population sars-cov-2 seroprevalence weighted age sex geographic area resultsparticipation rate 3 1 dublin sligo thirty-three specimen detectable sars-cov-2 antibody 9 estimated weighted seroprevalences12 confidence interval ci 05-458 ci 18-1 dublin sligo 69 ci 13-2 nationally equates estimated482 ci 772-85 people aged 12-69 year nationally infection sars-cov-2 0 ci 0-4 time higher confirmed notification ten participant reported previous laboratory-confirmed sars-cov-2 -infection eight antibody-positive twenty-five antibody-positive participant reported previous laboratory-confirmed infection conclusionthe majority people ireland unlikely infected sars-cov-2 june-july non-pharmaceutical public health measure remained key pending widespread availability vaccination effective treatment'\n",
      "Label(s): ['Humans' 'SARS-CoV-2' 'COVID-19*' 'Cross-Sectional Studies'\n",
      " 'Antibodies, Viral' 'Seroepidemiologic Studies' 'Ireland / epidemiology']\n",
      "Predicted Label(s): (Humans, SARS-CoV-2, COVID-19*, Pandemics, Female, Male, Adult)\n",
      " \n",
      "Abstract: b'integrated care needed ever professional perspective sara-marie black offer personal account lastmonth emotional personal professional impact presenting unprecedented challenge covid-19 also provided opportunity learn reflect emphasised need ever work collaboratively across health social voluntary community social enterprise sector'\n",
      "Label(s): ['Humans' 'SARS-CoV-2' 'COVID-19*' 'Delivery of Health Care, Integrated*']\n",
      "Predicted Label(s): (Humans, SARS-CoV-2, COVID-19*, Pandemics, Female, Male, Adult, Middle Aged, Cross-Sectional Studies, Retrospective Studies, Child, COVID-19 / virology, COVID-19* / epidemiology, Aged, Animals, Young Adult, SARS-CoV-2*, Adolescent, Surveys and Questionnaires, COVID-19 Vaccines, Communicable Disease Control, COVID-19 / epidemiology, Pandemics*, Vaccination, COVID-19 / epidemiology*, Risk Factors, COVID-19* / prevention &amp; control, SARS-CoV-2 / isolation &amp; purification, SARS-CoV-2 / immunology*, Aged, 80 and over, Prospective Studies, Treatment Outcome, Cohort Studies, Health Personnel, Pregnancy, COVID-19 / immunology, United States, Antibodies, Viral, United States / epidemiology, COVID-19 / prevention &amp; control, Child, Preschool, COVID-19 / prevention &amp; control*, Severity of Illness Index, Intensive Care Units, COVID-19 / immunology*, COVID-19 / diagnosis*, Infant, SARS-CoV-2 / genetics, SARS-CoV-2 / genetics*, Pandemics / prevention &amp; control, Mice, COVID-19 / complications*, Sensitivity and Specificity, COVID-19 Vaccines*, SARS-CoV-2 / pathogenicity, COVID-19 Testing, COVID-19* / drug therapy, COVID-19* / complications, Hospitalization, SARS-CoV-2 / immunology, Mutation, Infant, Newborn, COVID-19 / diagnosis, Incidence, Prevalence, Anxiety / epidemiology, Mental Health, Longitudinal Studies, Telemedicine*, Delivery of Health Care, Public Health, COVID-19 / pathology, Hospitals, Depression / epidemiology, China, Prognosis, COVID-19 / mortality, COVID-19 / psychology*, Disease Outbreaks, COVID-19 / drug therapy*, Quality of Life, China / epidemiology, SARS-CoV-2 / drug effects*, COVID-19 / complications, Reproducibility of Results, Spike Glycoprotein, Coronavirus / genetics, COVID-19 Vaccines / immunology*, Students, COVID-19 / virology*, BNT162 Vaccine, Spike Glycoprotein, Coronavirus / immunology, mRNA Vaccines, COVID-19* / diagnosis, Vaccines*, Comorbidity, Pandemics* / prevention &amp; control, Qualitative Research, SARS-CoV-2 / physiology, Vero Cells, Case-Control Studies, COVID-19, COVID-19 / drug therapy, SARS-CoV-2 / isolation &amp; purification*, Antibodies, Viral / blood, Protein Binding, Antibodies, Neutralizing / immunology, Spike Glycoprotein, Coronavirus / immunology*, Antibodies, Neutralizing, COVID-19 / transmission, RNA, Viral, HEK293 Cells, Antiviral Agents / pharmacology, Spike Glycoprotein, Coronavirus / metabolism, COVID-19* / therapy, Antibodies, Viral / immunology*, COVID-19 / therapy, Follow-Up Studies, Social Media*, COVID-19 / blood, Vaccines, Synthetic, Vaccination Hesitancy, COVID-19 / mortality*, Spike Glycoprotein, Coronavirus, Antiviral Agents / therapeutic use, Time Factors, COVID-19 / blood*, Students, Medical*, Vaccination / adverse effects, COVID-19 / metabolism, SARS-CoV-2 / metabolism, Models, Theoretical, Antibodies, Viral / immunology, COVID-19 Vaccines / administration &amp; dosage, Chlorocebus aethiops, Primary Health Care, Tomography, X-Ray Computed, Italy / epidemiology, COVID-19 / therapy*, Antibodies, Viral / blood*, COVID-19 Vaccines / adverse effects, RNA, Viral / genetics, SARS-CoV-2 / drug effects, Algorithms, Cell Line, Exercise, Republic of Korea / epidemiology, COVID-19 / pathology*, Tertiary Care Centers, Schools, Age Factors, SARS-CoV-2* / genetics, Angiotensin-Converting Enzyme 2 / metabolism, Immunoglobulin G / blood, Health Knowledge, Attitudes, Practice, Masks, SARS-CoV-2 / metabolism*, Antiviral Agents / pharmacology*, Phylogeny, Brazil / epidemiology, Environmental Monitoring, Molecular Docking Simulation, Lung, Hospital Mortality, Seroepidemiologic Studies, United Kingdom / epidemiology, Critical Illness, Angiotensin-Converting Enzyme 2 / genetics, SARS-CoV-2 / physiology*, Binding Sites, Depression, Viral Load, Perception, Adaptation, Psychological, Respiration, Artificial, Emotions, Randomized Controlled Trials as Topic, Inflammation, Students, Nursing*, Antibody Formation, COVID-19 Vaccines / administration &amp; dosage*, Anxiety, COVID-19 / physiopathology, Particulate Matter / analysis, Disease Models, Animal, Quarantine, Immunization, Passive, Databases, Factual, Molecular Dynamics Simulation, India, COVID-19 / genetics*, Seasons, Physical Distancing, Trust, Biomarkers, Policy, COVID-19 Vaccines / immunology, Oxygen Saturation, India / epidemiology, Universities, Biosensing Techniques*, COVID-19 / genetics, Education, Distance*, Mental Health*, COVID-19* / immunology, Influenza, Human* / epidemiology, Brazil, Critical Care, Deep Learning*, United Kingdom, Immunoglobulin G, Immunity, Innate, Communication, Japan / epidemiology, Air Pollutants* / analysis, Spike Glycoprotein, Coronavirus / chemistry, Host-Pathogen Interactions, Canada, Risk Assessment, Attitude, Logistic Models, Global Health, Stress, Psychological / epidemiology, COVID-19 / transmission*, Sociodemographic Factors, Spain / epidemiology, RNA, Messenger, Internet, Saudi Arabia / epidemiology, Pandemics / prevention &amp; control*, COVID-19 / metabolism*, Lung / diagnostic imaging, Psychological Distress*, Transplant Recipients, Spike Glycoprotein, Coronavirus / genetics*, Australia / epidemiology, Pilot Projects, Lung / virology, Parents, Registries, Artificial Intelligence, SARS-CoV-2 / classification, Sex Factors, Mice, Inbred C57BL, SARS-CoV-2 / pathogenicity*, Antiviral Agents / chemistry, Forecasting, Government, Angiotensin-Converting Enzyme 2 / metabolism*, Minority Groups, Vaccine Development, Air Pollution* / analysis, COVID-19 Vaccines / adverse effects*, Machine Learning, Mice, Inbred BALB C, South Africa, Antibodies, Neutralizing / immunology*, COVID-19 / physiopathology*, Intention, Bangladesh / epidemiology, Disease Progression, Diagnostic Tests, Routine, ROC Curve, Vaccine Efficacy, South Africa / epidemiology, Immunogenicity, Vaccine, Antiviral Agents / therapeutic use*, Neutralization Tests, Neural Networks, Computer, Cytokines / metabolism, Hospitalization / statistics &amp; numerical data*, Real-Time Polymerase Chain Reaction, Italy, Epidemics*, Physicians*, Virus Internalization, Neoplasms* / epidemiology, Double-Blind Method, Spike Glycoprotein, Coronavirus / metabolism*, Length of Stay, Emergency Service, Hospital, COVID-19* / mortality, COVID-19 Nucleic Acid Testing, Australia, Socioeconomic Factors, Health Services Accessibility, Ethnicity, Disease Outbreaks / prevention &amp; control, Cells, Cultured, Biomarkers / blood, Research Design, Personal Protective Equipment, Nursing Homes, Bayes Theorem, Pharmaceutical Preparations*, Antibodies, Neutralizing / blood, HIV Infections* / epidemiology, ChAdOx1 nCoV-19, Mice, Transgenic)\n",
      " \n",
      "Abstract: b'single-agent extension sir model describes impact mobility restriction covid-19 epidemic mobility restriction successfully used contain diffusion epidemic work explore effect epidemic growth investigating extension susceptible-infected-removed sir model individual mobility taken account model individual agent move chessboard levy walk within square epidemic spreading follows standard sir model simple rule allow reproduce sub-exponential growth epidemic evolution observed covid-19 epidemic wave several country cannot captured standard sir model show tune slowing-down epidemic spreading changing dynamic agent levy brownian investigate interplay among different containment strategy mitigate epidemic spreading finally demonstrate reproduce epidemic evolution first second covid-19 wave italy usingparameter e infection rate removing rate mobility country provide estimate peak reduction due imposed mobility restriction e so-called flattening curve effect although based ingredient model capture kinetic epidemic wave returning mobility value consistent lock-down intervention first wave milder limitation associated weaker peak reduction second wave'\n",
      "Label(s): ['Humans' 'COVID-19 / virology' 'COVID-19 / epidemiology*'\n",
      " 'SARS-CoV-2 / isolation &amp; purification' 'Italy / epidemiology'\n",
      " 'Models, Theoretical*' 'Movement*' 'Epidemics']\n",
      "Predicted Label(s): (Humans, SARS-CoV-2, COVID-19*, Pandemics, Male, Female, Adult, Middle Aged)\n",
      " \n",
      "Abstract: b'phytocompounds anvillea radiata promising anti-covid-19 drug silico study vivo safety assessment alternative strategy combating covid-19 pandemic phytoconstituents medicinal plant getting attention worldwide current investigation focused efficacy essential phytocompounds identified anvillea radiata target main protease pro sars-cov-2 molecular docking dynamic analysis addition safety assessment herb vivo silico 6lu7 structure pro prepared target discovery studio virtual screening phytocompounds anvillea radiata performed igemdock program followed evaluation potential inhibitor based docking score calculated using autodock vina mgl tool program well complex stability assessment md simulation vivo toxicity study anvillea radiata aqueous extract also conducted wistar rat among phytocompounds evaluated study 5-dicaffeoylquinic acid spinacetin 9alpha-epoxyparthenolide hispidulin quercetin jaceosidin nepetin isorhamnetin predicted highest binding affinity main protease pro target sars-cov-2 aqueous extract anvillea radiata induce sign toxicity 5-dicaffeoylquinic acid spinacetin 9alpha-epoxyparthenolide jaceosidin isorhamnetin anvillea radiata selected potential inhibitor sars-cov-2 develop new drug anti-covid-19'\n",
      "Label(s): ['[UNK]' 'Humans' 'SARS-CoV-2' 'Pandemics' 'Animals'\n",
      " 'COVID-19* / drug therapy' 'Molecular Docking Simulation' 'Rats'\n",
      " 'Protease Inhibitors / pharmacology' 'Protease Inhibitors / chemistry']\n",
      "Predicted Label(s): (Humans, SARS-CoV-2, COVID-19*, Pandemics, Female, Male, Adult)\n",
      " \n",
      "Abstract: b'adult meeting fruit vegetable intake recommendation - united state 2020-2025 dietary guideline american advise incorporating fruit vegetable u resident diet part healthy dietary pattern adult consume5-2 cup-equivalents fruit 2-3 cup-equivalents vegetable daily dagger healthy diet support healthy immune function help prevent obesity typediabetes cardiovascular disease cancer condition predispose person severe illness death covid-19 cdc used recentbehavioral risk factor surveillance system brfss data estimate percentage state adult population met intake recommendation overall sociodemographic characteristicstate district columbia dc overall 3 adult met fruit recommendation ranging4 west virginia1 connecticut 0 met vegetable recommendation ranging6 kentucky0 vermont prevalence meeting fruit intake recommendation highest among hispanic adult 4 lowest among male 1 meeting vegetable intake recommendation highest among adult aged > year 5 lowest among living close poverty level income poverty ratio ipr <1 8 additional policy section sign program increase access fruit vegetable place u resident live learn work play might increase consumption improve health'\n",
      "Label(s): ['[UNK]' 'Humans' 'Female' 'Male' 'Adult' 'Middle Aged' 'United States'\n",
      " 'Sociodemographic Factors' 'Fruit*']\n",
      "Predicted Label(s): (Humans, SARS-CoV-2, COVID-19*, Pandemics, Male, Female, Adult, Middle Aged)\n",
      " \n"
     ]
    }
   ],
   "source": [
    "# Create a model for inference.\n",
    "model_for_inference = keras.Sequential([text_vectorizer, shallow_mlp_model])\n",
    "top_prob = []\n",
    "\n",
    "# Create a small dataset just for demoing inference.\n",
    "inference_dataset = make_dataset(test_df.sample(100), is_train=False)\n",
    "text_batch, label_batch = next(iter(inference_dataset))\n",
    "predicted_probabilities = model_for_inference.predict(text_batch)\n",
    "for prob in predicted_probabilities:\n",
    "    top_prob.append(prob[prob > 0.105])\n",
    "\n",
    "# Perform inference.\n",
    "for i, text in enumerate(text_batch[:5]):\n",
    "    label = label_batch[i].numpy()[None, ...]\n",
    "    print(f\"Abstract: {text}\")\n",
    "    print(f\"Label(s): {invert_multi_hot(label[0])}\")\n",
    "    predicted_proba = [proba for proba in top_prob[i]]\n",
    "    top_labels = [\n",
    "        x for _, x in sorted(\n",
    "            zip(top_prob[i], lookup.get_vocabulary()),\n",
    "            key=lambda pair: pair[0],\n",
    "            reverse=True,)]\n",
    "    top_labels.remove('[UNK]')\n",
    "    print(f\"Predicted Label(s): ({', '.join([label for label in top_labels])})\")\n",
    "    print(\" \")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9bc3c232",
   "metadata": {},
   "source": [
    "## TODO: Add Titles into model, with seperate vectorisation and weights to abstract \n",
    "## Stratify our dataset \n",
    "## Finetune model (use laxer activation function)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "id": "e084c99f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'[UNK]'"
      ]
     },
     "execution_count": 143,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "top_labels[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "63e0c7a3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
